scph-10q_20210331.htm

0001564590-21-026969.txt : 20210512 0001564590-21-026969.hdr.sgml : 20210512 20210512160040 ACCESSION NUMBER: 0001564590-21-026969 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 64 CONFORMED PERIOD OF REPORT: 20210331 FILED AS OF DATE: 20210512 DATE AS OF CHANGE: 20210512 FILER: COMPANY DATA: COMPANY CONFORMED NAME: scPharmaceuticals Inc. CENTRAL INDEX KEY: 0001604950 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465184075 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-38293 FILM NUMBER: 21914973 BUSINESS ADDRESS: STREET 1: 2400 DISTRICT AVENUE STREET 2: SUITE 310 CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: 617-517-0730 MAIL ADDRESS: STREET 1: 2400 DISTRICT AVENUE STREET 2: SUITE 310 CITY: BURLINGTON STATE: MA ZIP: 01803 10-Q 1 scph-10q_20210331.htm 10-Q scph-10q_20210331.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2021

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 001-38293

SCPHARMACEUTICALS INC.

(Exact name of registrant as specified in its charter)

Delaware

46-5184075

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

2400 District Avenue, Suite 310

01803 Burlington, Massachusetts (Zip Code)

(Address of principal executive office)

Registrant’s telephone number, including area code: (617) 517-0730

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common stock, par value $0.0001	SCPH	The Nasdaq Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of May 11, 2021, the Registrant had 27,355,454 common shares, $0.0001 par value per share, outstanding.

FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains express or implied forward-looking statements that are based on our management’s belief and assumptions and on information currently available to our management. Although we believe that the expectations reflected in these forward-looking statements are reasonable, these statements relate to future events or our future operational or financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements in this Quarterly Report on Form 10-Q include, but are not limited to, statements about:

•

the completion of activities required for the resubmission of the FUROSCIX^® new drug application, or NDA, with the SmartDose drug delivery system on our current projected timelines and subsequent review and potential approval by the U.S. Food and Drug Administration, or FDA, including any delays in submission or approval related to COVID-19;

•

the likelihood of approval by the FDA of our regulatory filings for FUROSCIX using our next generation delivery device;

	•	the timing or likelihood of other regulatory filings and approvals;
	•	the outcome of any bridging studies, clinical trials or human factors studies that may be required by the FDA for approval of any of our product candidates;

•

the commercialization of FUROSCIX, if approved, including launch preparation, ability to interact with physicians, patient access to FUROSCIX, manufacturing and supply chain, including any delays related to COVID-19 in our ongoing Health Economics and Outcomes Research study and future planned Phase 4 studies of FUROSCIX incorporating the SmartDose drug delivery system to support the pricing and access to our product candidates;

•

the pricing and reimbursement of FUROSCIX or any other of our product candidates, if approved;

•

the rate and degree of market acceptance and clinical utility of FUROSCIX or any other of our product candidates for which we receive marketing approval;

•

the initiation, timing, progress and results of our research and development programs, including future preclinical and clinical studies;

•

our ability to advance any other product candidates into, and successfully complete, clinical studies and obtain regulatory approval for them;

•

our ability to identify additional product candidates;

•

the implementation of our strategic plans for our business, product candidates and technology;

•

the scope of protection we are able to establish and maintain for intellectual property rights covering FUROSCIX or any other of our product candidates and technology;

•

estimates of our expenses, future revenues, capital requirements and our needs for additional financing;

•

our ability to manufacture, or the ability of third parties to deliver, sufficient quantities of components and drug product for commercialization of FUROSCIX or any other of our product candidates;

•

our ability to maintain and establish collaborations;

•

our financial performance;

•

developments relating to our competitors and our industry, including the impact of government regulation; and

•

other risks and uncertainties, including those listed under the caption “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2020.

In some cases, forward-looking statements can be identified by terminology such as “may,” “should,” “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “continue” or the negative of these terms or other comparable terminology. These statements are only predictions. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors, which are, in some cases, beyond our control and which could materially affect results. Factors that may cause actual results to differ materially from current expectations include, among other things, those set forth in Item 1A, “Risk Factors” and elsewhere in our Annual Report on Form 10-K for the year ended December 31, 2020, which was filed with the Securities and Exchange Commission on March 23, 2021, as well as in our subsequent filings with the Securities and Exchange Commission. If one or more of these risks or uncertainties occur, or if our underlying assumptions prove to be incorrect, then actual events or results may vary significantly from those implied or projected by the forward-looking statements. No forward-looking statement is a guarantee of future performance. While we may elect to update these forward-looking statements at some point in the future, we have no current intention of doing so except to the extent required by applicable law. You should therefore not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this Quarterly Report on Form 10-Q.

SCPHARMACEUTICALS INC.

INDEX

		Page

PART I – FINANCIAL INFORMATION

Item 1.	Condensed Consolidated Financial Statements (unaudited)
	Condensed Consolidated Balance Sheets as of December 31, 2020 and March 31, 2021	1
	Condensed Consolidated Statements of Operations and Comprehensive Loss for the Three Months Ended March 31, 2020 and March 31, 2021	2
	Condensed Consolidated Statements of Stockholders’ Equity for the Three Months Ended March 31, 2020 and March 31, 2021	3
	Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2020 and March 31, 2021	4
	Notes to Condensed Consolidated Financial Statements	5

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	14

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	18

Item 4.	Controls and Procedures	19

PART II – OTHER INFORMATION

Item 1.	Legal Proceedings	20
Item 1A.	Risk Factors	20
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	20
Item 3.	Defaults Upon Senior Securities	20
Item 4.	Mine Safety Disclosures	20
Item 5.	Other Information	20
Item 6.	Exhibits	20

Exhibit Index		21
Signatures		22

PART I — FINANCIAL INFORMATION

SCPHARMACEUTICALS INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except share and per share amounts)

(Unaudited)

	December 31,			March 31,
	2020			2021
Assets
Current assets
Cash and cash equivalents	$	71,819		$	75,837
Short-term investments		33,276			20,490
Prepaid expenses		2,610			2,637
Other current assets		121			102
Total current assets		107,826			99,066
Restricted cash		182			182
Property and equipment, net		93			85
Right-of-use lease assets - operating, net		815			717
Deposits and other assets		132			243
Total assets	$	109,048		$	100,293
Liabilities and Stockholders’ Equity
Current liabilities
Accounts payable	$	1,666		$	753
Accrued expenses		4,787			3,585
Term loan, short-term		2,408			4,838
Lease obligation - operating, short-term		460			472
Total current liabilities		9,321			9,648
Term loan, long-term		16,858			14,515
Lease obligation - operating, long-term		480			356
Other liabilities		219			259
Total liabilities		26,878			24,778
Commitments and contingencies (Note 11)
Stockholders’ equity
Preferred stock, $0.0001 par value; 10,000,000 shares authorized and no shares issued and outstanding		-			-
Common stock, $0.0001 par value; 150,000,000 shares authorized as of March 31, 2021; 27,325,959 and 27,355,453 shares issued and outstanding as of December 31, 2020 and March 31, 2021, respectively		3			3
Additional paid-in capital		243,830			244,279
Accumulated deficit		(161,664	)		(168,766	)
Accumulated other comprehensive gain (loss)		1			(1	)
Total stockholders’ equity		82,170			75,515
Total liabilities and stockholders’ equity	$	109,048		$	100,293

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

SCPHARMACEUTICALS INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(In thousands, except share and per share amounts)

(Unaudited)

	Three Months Ended March 31,
	2020			2021
Operating expenses:
Research and development	$	4,146		$	4,009
General and administrative		2,503			2,732
Total operating expenses		6,649			6,741
Loss from operations		(6,649	)		(6,741	)
Other (expense) income		(31	)		255
Interest income		224			20
Interest expense		(636	)		(636	)
Net loss	$	(7,092	)	$	(7,102	)
Net loss per share — basic and diluted	$	(0.35	)	$	(0.26	)
Weighted average common shares outstanding — basic and diluted		20,218,473			27,336,724

Other comprehensive loss:
Unrealized loss on short-term investments	$	-		$	(2	)
Comprehensive loss	$	(7,092	)	$	(7,104	)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

SCPHARMACEUTICALS INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(In thousands, except share amounts)

(Unaudited)

					ADDITIONAL						OTHER			TOTAL
	COMMON STOCK				PAID-IN			ACCUMULATED			COMPREHENSIVE			STOCKHOLDERS'
	SHARES		AMOUNT		CAPITAL			DEFICIT			INCOME			EQUITY
At December 31, 2020		27,325,959	$	3	$	243,830		$	(161,664	)	$	1		$	82,170
Net loss		—		—		—			(7,102	)		—			(7,102	)
Issuance of common stock upon exercise of stock options		2,500		—		9			—			—			9
Vesting of restricted stock		26,994		—		(81	)		—			—			(81	)
Stock-based compensation		—		—		521			—			—			521
Unrealized loss on short-term investments		—		—		—			—			(2	)		(2	)
At March 31, 2021		27,355,453	$	3	$	244,279		$	(168,766	)	$	(1	)	$	75,515

At December 31, 2019		19,418,955	$	2	$	180,818		$	(129,455	)	$	—		$	51,365
Net loss		—		—		—			(7,092	)		—			(7,092	)
Issuance of common stock under at-the-market offering net of commissions and issuance costs (Note 9)		1,502,892		—		10,253			—			—			10,253
Issuance of common stock upon exercise of stock options		30,143		—		154			—			—			154
Vesting of restricted stock		29,890		—		(84	)		—			—			(84	)
Stock-based compensation		—		—		508			—			—			508
At March 31, 2020		20,981,880	$	2	$	191,649		$	(136,547	)	$	—		$	55,104

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

SCPHARMACEUTICALS INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

	Three Months Ended March 31,
	2020			2021
Cash flows from operating activities
Net loss	$	(7,092	)	$	(7,102	)
Adjustments to reconcile net loss to cash used in operating activities
Depreciation expense		8			8
Amortization expense - right-of-use leased assets - operating		87			98
Accretion expense		-			79
Stock-based compensation		508			521
Non-cash interest expense		121			127
Fair value adjustment to derivative liability		30			-
Changes in operating assets and liabilities
Prepaid expenses and other assets		(720	)		(119	)
Accounts payable, accrued expenses and other liabilities		(685	)		(2,227	)
Net cash used in operating activities		(7,743	)		(8,615	)
Cash flows from investing activities
Maturities of short-term investments		-			16,700
Purchases of short-term investments		-			(3,995	)
Net cash provided by investing activities		-			12,705
Cash flows from financing activities
Proceeds from at-the-market offering, net		10,388			-
Proceeds from the exercise of vested stock options		154			9
Settlements of restricted stock units for tax withholding obligations		(84	)		(81	)
Net cash provided by (used in) financing activities		10,458			(72	)
Net increase in cash, cash equivalents and restricted cash		2,715			4,018
Cash, cash equivalents and restricted cash at beginning of period		72,806			72,001
Cash, cash equivalents and restricted cash at end of period	$	75,521		$	76,019
Supplemental cash flow information
Interest paid	$	518		$	597
Taxes paid	$	-		$	42
Supplemental non-cash information
Transfer of issuance costs from other noncurrent assets to equity	$	135		$	-

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

SCPHARMACEUTICALS INC.

Notes to Unaudited Condensed Consolidated Financial Statements

1. Description of Business and Basis of Presentation

Description of Business

scPharmaceuticals LLC was formed as a limited liability company under the laws of the State of Delaware on February 19, 2013. On March 24, 2014, scPharmaceuticals LLC was converted to a Delaware corporation and changed its name to scPharmaceuticals Inc. (“the Company”). The Company is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The Company’s strategy is designed to enable the subcutaneous administration of therapies that have previously been limited to intravenous (“IV”) delivery. The Company’s headquarters and primary place of business is Burlington, Massachusetts.

Basis of Presentation

The accompanying condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and have been prepared on a basis which assumes that the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. The condensed consolidated financial statements reflect the operations of the Company and its wholly-owned subsidiary, scPharmaceuticals Securities Corporation. Certain information and disclosures normally included in financial statements in accordance with U.S. GAAP have been condensed or omitted. Accordingly, these condensed consolidated financial statements should be read in conjunction with the Company’s audited financial statements and related notes for the year ended December 31, 2020 included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) on March 23, 2021. The Company has determined that it operates in one segment.

The accompanying condensed consolidated balance sheet as of March 31, 2021, the condensed consolidated statements of operations and comprehensive loss and stockholders’ equity for the three months ended March 31, 2020 and 2021 and condensed consolidated statements of cash flows for the three months ended March 31, 2020 and 2021 are unaudited. The unaudited condensed consolidated financial statements have been prepared on a basis consistent with that used to prepare the Company’s audited annual financial statements and include, in the opinion of management, adjustments, consisting of normal recurring items, necessary for the fair statement of the condensed consolidated financial statements. The operating results for the three months ended March 31, 2021 are not necessarily indicative of the results expected for the full year ending December 31, 2021.

Liquidity

As of March 31, 2021, the Company had an accumulated deficit of approximately $168.8 million. Management expects to continue to incur operating losses for the foreseeable future. The Company has financed its operations to date from proceeds from the sale of common stock, preferred stock and the incurrence of debt.

As of March 31, 2021, the Company had cash, cash equivalents, restricted cash, and short-term investments of $96.5 million. The Company believes that its existing cash, cash equivalents, restricted cash and short-term investments will be sufficient to meet its cash commitments for at least the next 12 months after the date that the interim condensed consolidated financial statements are issued.

2. Significant Accounting Policies

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reported periods. Actual results could differ from those estimates.

Cash, Cash Equivalents and Restricted Cash

from the date of purchase to be cash equivalents. The Company’s cash and cash equivalent accounts, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts.

As of March 31, 2021, the Company classified $182,000 as restricted cash related to a letter of credit issued as a security deposit in connection with the Company’s lease of its corporate office facilities (Note 11). Cash, cash equivalents and restricted cash consists of the following (in thousands):

	December 31, 2020		March 31, 2021
Cash and cash equivalents	$	71,819	$	75,837
Restricted cash		182		182
Cash, cash equivalents and restricted cash	$	72,001	$	76,019

Concentration of Credit Risk

Financial instruments that subject the Company to credit risk primarily consist of cash and cash equivalents and short-term investments. The Company maintains its cash and cash equivalent balances with high-quality financial institutions and, consequently, the Company believes that such funds are subject to minimal credit risk. The Company’s short-term investments consist of United States Treasury securities, corporate debt securities and commercial paper. The Company has adopted an investment policy that limits the amounts the Company may invest in any one type of investment and requires all investments held by the Company to hold a minimum rating, thereby reducing credit risk exposure.

Investments

The Company invests excess cash balances in available-for-sale debt securities. The Company determines the appropriate classification of these securities at the time they are acquired and evaluates the appropriateness of such classifications at each balance sheet date. The Company reports available-for-sale investments at fair value at each balance sheet date and includes any unrealized gains and losses in accumulated other comprehensive income (loss), a component of stockholders’ equity. Realized gains and losses are determined using the specific identification method and are included in other income (expense). If any adjustment to fair value reflects a decline in the value of the investment, the Company considers all available evidence to evaluate the extent to which the decline is “other than temporary,” including the intention to sell and, if so, marks the investment to market through a charge to the Company’s consolidated statements of operations and comprehensive loss.

Leases

The Company determines if an arrangement is a lease at inception. Operating leases are included in right-of-use (“ROU”) lease assets, current portion of lease obligations, and long-term lease obligations on the Company’s balance sheets.

ROU lease assets represent the Company’s right to use an underlying asset for the lease term and lease obligations represent the Company’s obligation to make lease payments arising from the lease. Operating ROU lease assets and obligations are recognized at the commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The ROU lease asset excludes lease incentives. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.

Income Taxes

The Company accounts for income taxes in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) 740, Income Taxes. Deferred tax assets and liabilities are recorded to reflect the impact of temporary differences between amounts of assets and liabilities for financial reporting purposes and such amounts as measured under enacted tax laws. A valuation allowance is required to offset any net deferred tax assets if, based upon the available evidence, it is more likely than not that some or all of the deferred tax asset will not be realized.

The Company provides reserves for potential payments of tax to various tax authorities related to uncertain tax positions. The tax benefits recorded are based on a determination of whether and how much of a tax benefit taken by the Company in its tax filings or positions is “more likely than not” to be realized following resolution of any uncertainty related to the tax benefit, assuming that the matter in question will be raised by the tax authorities. Potential interest and penalties associated with such uncertain tax positions are recorded as a component of income tax expense. At March 31, 2021, the Company had no such accruals.

3. Net Loss per Share

Net Loss per Share Attributable to Common Stockholders

The following table sets forth the computation of basic and diluted net loss per share of common stock (in thousands, except share and per share data):

	Three Months Ended March 31,
	2020			2021
Net loss	$	(7,092	)	$	(7,102	)
Weighted-average shares used in computing net loss per share		20,218,473			27,336,724
Net loss per share, basic and diluted	$	(0.35	)	$	(0.26	)

The Company’s potentially dilutive securities, which include stock options and unvested restricted stock units, have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share. Therefore, the weighted average number of common shares outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same. The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect.

	Three Months Ended March 31,
	2020		2021
Stock options to purchase common stock		2,058,355		2,805,029
Unvested restricted stock units		122,700		42,250
Total		2,181,055		2,847,279

4. Investments

Cash in excess of the Company’s immediate requirements is invested in accordance with the Company’s investment policy that primarily seeks to maintain adequate liquidity and preserve capital.

A summary of the Company’s available-for-sale classified investments as of March 31, 2021 consisted of the following (in thousands):

	At March 31, 2021
Investments - Current:	Cost Basis		Accumulated Unrealized Gains		Accumulated Unrealized Losses			Fair Value
United States Treasury securities	$	3,705	$	1	$	-		$	3,706
Corporate debt securities		6,894		-		(2	)		6,892
Commercial paper		9,892		-		-			9,892
Total	$	20,491	$	1	$	(2	)	$	20,490

The amortized cost and fair value of the Company’s available-for-sale investments, by contract maturity, as of March 31, 2021 consisted of the following (in thousands):

	Amortized Cost		Fair Value
Due in one year or less	$	20,491	$	20,490
Total	$	20,491	$	20,490

5. Property and Equipment

Purchased property and equipment consist of the following (dollars in thousands):

	ESTIMATED USEFUL LIFE	December 31, 2020			March 31, 2021
Office equipment	5 years	$	10		$	10
Office furniture	7 years		116			116
Computer equipment	3 years		8			8
Leasehold improvements	Life of lease		95			95
			229			229
Less: Accumulated depreciation			(136	)		(144	)
Property and equipment, net		$	93		$	85

Depreciation expense for the three months ended March 31, 2020 and March 31, 2021 was $8,000 and $8,000, respectively.

6. Accrued Expenses

Accrued expenses consist of the following (in thousands):

	December 31, 2020		March 31, 2021
Contract research and development	$	2,274	$	2,467
Employee compensation and related costs		1,978		689
Consulting and professional service fees		364		203
Interest		88		88
Financing related costs		43		86
State taxes		40		52
Total accrued expenses	$	4,787	$	3,585

7. Fair Value of Financial Instruments

The Financial Accounting Standards Board (“FASB”) Accounting Standard Codification (“ASC”) Topic, Fair Value Measurements and Disclosures (“ASC 820”), provides a fair value hierarchy, which classifies fair value measurements based on the inputs used in measuring fair value. Observable inputs are inputs that market participants would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions about the inputs that market participants would use in pricing the asset or liability, and are developed based on the best information available in the circumstances. The fair value hierarchy applies only to the valuation inputs used in determining the reported fair value of the investments and is not a measure of the investment credit quality. The three levels of the fair value hierarchy are described below:

Level 1—Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.

Level 2—Valuations based on quoted prices for similar assets or liabilities in markets that are not active or for which all significant inputs are observable, either directly or indirectly.

Level 3—Valuations that require inputs that reflect the Company’s own assumptions that are both significant to the fair value measurement and observable.

To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized in Level 3. A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.

The carrying values of the Company’s cash and restricted cash, prepaid expenses and deposits approximate their fair values due to their short-term nature. The carrying value of the Company’s loan payable was considered a reasonable estimate of fair value because the Company’s interest rate is near current market rates for instruments with similar characteristics.

The following tables summarize the Company’s assets that are measured at fair value on a recurring basis and indicates the level of the fair value hierarchy utilized to determine such fair values (in thousands):

	As of December 31, 2020
	TOTAL		Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets:
Cash equivalents	$	70,797	$	68,798	$	1,999	$	—
Total cash equivalents		70,797		68,798		1,999		—

United States Treasury securities		8,213		8,213		—		—
Corporate debt securities		11,973		—		11,973		—
Commercial paper		13,090		—		13,090		—
Investments		33,276		8,213		25,063		—

Total	$	104,073	$	77,011	$	27,062	$	—


	As of March 31, 2021
	TOTAL		Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets:
Cash equivalents	$	75,115	$	75,115	$	—	$	—
Total cash equivalents		75,115		75,115		—		—

United States Treasury securities		3,706		3,706		—		—
Corporate debt securities		6,892		—		6,892		—
Commercial paper		9,892		—		9,892		—
Investments		20,490		3,706		16,784		—

Total	$	95,605	$	78,821	$	16,784	$	—

8. Term Loan

In May 2017, the Company entered into a loan and security agreement (the “2017 Loan Agreement”), with SLR Investment Corp. (f/k/a Solar Capital Ltd.) and Silicon Valley Bank (together, the “Lenders”), for $10.0 million. The 2017 Loan Agreement had a maturity date of May 1, 2021. Debt issuance costs for the 2017 Loan Agreement were to be amortized to interest expense over the remaining term of the 2017 Loan Agreement using the effective-interest method.

In September 2019, the Company replaced the 2017 Loan Agreement with a new $20.0 million term loan with the Lenders (the “2019 Loan Agreement”). The restructured four-year term loan facility allows for an expansion of the 2017 Loan Agreement. Some of the proceeds from the 2019 Loan Agreement were used to pay off the 2017 Loan Agreement including the final fee of $325,000. The 2019 Loan Agreement extends the term of the credit facility until September 17, 2023. The payoff of the 2017 Loan Agreement was treated as a modification of the debt. Debt issuance costs for the 2019 Loan Agreement, including unamortized issuance costs for the 2017 Loan Agreement, will be amortized to interest expense over the remaining term of the 2019 Loan Agreement using the effective-interest method.

The interest rate under the 2019 Loan Agreement is the higher of (i) LIBOR plus 7.95% or (ii) 10.18% and there is an interest-only period until September 30, 2021. The rate at March 31, 2021 was 10.18%. Pursuant to the 2019 Loan Agreement, the Company provided a first priority security interest in substantially all of the Company’s assets, including intellectual property, subject to certain exceptions.

separate unit of accounting. The Company recorded the issuance-date fair value of the derivative liability of $763,000 as a debt discount and as a derivative liability in the Company’s balance sheet. The derivative liability is re-measured at each balance sheet date and any changes in estimated fair value is recorded as other income (expense). The Company paid the Exit Fee during 2020 in conjunction with the Company’s public offering, which was deemed to be an exit event pursuant to the Exit Agreement. For the three months ended March 31, 2020, the Company recorded $30,000 in non-cash expense as a fair value adjustment to the derivative liability.

As of March 31, 2021, unpaid borrowings under the 2019 Loan Agreement totaled $20.0 million. For the three months ended March 31, 2021, the Company recorded $87,000 related to the amortization of debt discount associated with the 2019 Loan Agreement. For the three months ended March 31, 2020, the Company recorded $81,000 related to the amortization of debt discount associated with the 2019 Loan Agreement.

The 2019 Loan Agreement allows the Company to voluntarily prepay all (but not less than all) of the outstanding principal at any time. A prepayment premium of 3% or 1% through the one-year anniversary and the two-year anniversary, respectively, would be assessed on the outstanding principal. After the two-year anniversary, a 0.5% prepayment premium would be assessed on the outstanding principal. A final payment fee of $500,000 is due upon the earlier to occur of the maturity date or prepayment of such borrowings. For the three months ended March 31, 2021, the Company recorded $40,000 related to the amortization of the final payment fee associated with the 2019 Loan Agreement. For the three months ended March 31, 2020, the Company recorded $40,000 related to the amortization of the final payment fee associated with the 2019 Loan Agreement.

In an event of default under the 2019 Loan Agreement, the interest rate will be increased by 5% and the balance under the loan may become immediately due and payable at the option of the lenders.

The 2019 Loan Agreement includes restrictions on, among other things, the Company’s ability to incur additional indebtedness, change the name or location of the Company’s business, merge with or acquire other entities, pay dividends or make other distributions to holders of its capital stock, make certain investments, engage in transactions with affiliates, create liens, sell assets or pay subordinated debt.

Total term loan and unamortized debt discount balances are as follows (in thousands):

	March 31, 2021
Face value	$	20,000
Less: discount		(647	)
Total	$	19,353
Less: current portion		(4,838	)
Total	$	14,515

As of March 31, 2021, future principal payments due under the 2019 Loan Agreement are as follows (in thousands):

Year ended:
December 31, 2021	$	2,500
December 31, 2022		10,000
December 31, 2023		7,500
Total	$	20,000

9. Stockholders’ Equity

2019 At-the-Market Issuance Sales Agreement

On August 23, 2019, the Company entered into an Open Market Sale Agreement^SM (“2019 ATM Agreement”), with Jefferies LLC (“Jefferies”) with respect to an at-the-market offering program (the “2019 ATM Program”) under which the Company could offer and sell shares of its common stock (the “2019 ATM Shares”), having an aggregate offering price of up to $15.0 million through Jefferies as its sales agent. The offering and sale of 2019 ATM Shares were made pursuant to the Company’s shelf registration statement on Form S-3, which was declared effective by the SEC on February 11, 2019 (the “Registration Statement”).

The Company agreed to pay Jefferies a commission equal to 3.0% of the gross sales proceeds of such 2019 ATM Shares. The Company incurred $189,000 of legal, accounting and other costs to establish and activate the 2019 ATM program.

which completed the program. The Company charged $135,000 in costs related to establishing and activating the program against additional paid in capital upon issuance of shares during the three months ended March 31, 2020.

2021 At-the-Market Issuance Sales Agreement

On March 23, 2021, the Company entered into an Open Market Sale Agreement (the “2021 ATM Agreement”) with Cowen and Company, LLC (“Cowen”) with respect to an at-the-market offering program (the”2021 ATM Program”) under which the Company could offer and sell shares of its common stock (the “2021 ATM Shares”), having an aggregate offering price of up to $50.0 million through Cowen as its sales agent. The Company agreed to pay Cowen a commission up to 3.0% of the gross sales proceeds of such 2021 ATM Shares. As of March 31, 2021, the Company had received no proceeds from the sale of shares of common stock pursuant to the 2021 ATM Agreement.

10. Stock-Based Compensation

Stock Options

The Company’s 2017 Stock Option and Incentive Plan (the “2017 Stock Plan”) became effective in November 2017, upon the closing of the Company’s initial public offering and will expire in October 2027. Under the 2017 Stock Plan, the Company may grant incentive stock options, non-statutory stock options, restricted stock awards, restricted stock units (“RSUs”) and other stock-based awards. The Company’s 2014 Stock Incentive Plan (the “2014 Stock Plan”) was terminated in November 2017 upon the completion of the Company’s initial public offering and no further options were granted under the 2014 Stock Plan. At March 31, 2021, there were 600,688 options outstanding under the 2014 Stock Plan.

As of March 31, 2021, there were 5,051,921 shares of the Company’s common stock authorized for issuance under the 2017 Stock Plan, including 359,651 options that have been forfeited from the 2014 Stock Plan.

At March 31, 2021, there were 2,775,526 options available for issuance under the 2017 Stock Plan, 2,204,341 options outstanding and 42,250 RSUs outstanding. Awards granted under the 2017 Stock Plan have a term of ten years. Vesting of awards under the 2017 Stock Plan is determined by the board of directors, but, is generally over one to four-year terms.

The fair value of options at date of grant was estimated using the Black-Scholes option-pricing model with the following assumptions:

	Three Months Ended March 31,
	2020		2021
Risk-free interest rate	0.93% - 1.71%		0.50% - 0.72%
Expected dividend yield	0%		0%
Expected life	5.5-6.6 years		5.5-6.7 years
Expected volatility	72%-73%		72%-74%
Weighted-average grant date fair value	$	3.91	$	4.36

The following table summarizes information about stock option activity during the three months ended March 31, 2021 (in thousands, except share and per share data):

	NUMBER OF SHARES			WEIGHTED- AVERAGE EXERCISE PRICE		WEIGHTED- AVERAGE REMAINING CONTRACTUAL TERM		AGGREGATE INTRINSIC VALUE
Outstanding, December 31, 2020		2,224,913		$	6.26
Granted		785,406			6.84
Exercised		(2,500	)		3.81
Forfeited		(202,790	)		7.62
Outstanding, March 31, 2021		2,805,029		$	6.32		8.18	$	2,926
Vested and exercisable, March 31, 2021		1,125,780		$	5.66		6.64	$	2,222
Vested and expected to vest, March 31, 2021		2,013,825		$	6.26		7.76	$	2,541

Of the options granted during the three months ended March 31, 2021, 112,050 were performance-based options. Vesting of these performance-based options is contingent on the occurrence of certain regulatory and commercial milestones. The Company is recognizing the expense as straight-line over the expected performance achievement term.

The following table summarizes information about RSU activity during the three months ended March 31, 2021:

	RSUs			AVERAGE GRANT DATE FAIR VALUE (IN DOLLARS PER SHARE)
Outstanding, December 31, 2020		80,450		$	3.25
Granted		—			—
Vested		(38,200	)		3.25
Forfeited		—			—
RSUs outstanding at March 31, 2021		42,250		$	3.25

The number of RSUs vested includes shares of common stock withheld on behalf of employees to satisfy the minimum statutory tax withholding requirements.

Unrecognized compensation expense related to unvested options as of March 31, 2021 was $3.6 million and will be recognized over the remaining vesting periods of the underlying awards. The weighted-average period over which such compensation is expected to be recognized is 2.7 years. Unrecognized compensation expense related to unvested RSUs as of March 31, 2021 was $41,000 and will be recognized over the remaining vesting periods of the underlying awards. The weighted-average period over which such compensation is expected to be recognized is 1 year.

The Company recorded stock-based compensation expense in the following expense categories of its accompanying condensed consolidated statements of operations and comprehensive loss for the three months ended March 31, 2020 and 2021 (in thousands):

	Three Months Ended March 31,
	2020		2021
Research and development	$	144	$	226
General and administrative		364		295
Total	$	508	$	521

11. Commitments and Contingencies

Operating Leases

The Company leases office facilities and equipment under long-term, non-cancelable operating lease agreements. The leases expire at various dates through 2022 and do not include renewal options.

Certain leases provide for increases in future minimum annual rental payments as defined in the lease agreements. The leases generally also include real estate taxes and common area maintenance charges in the annual rental payments.

Pursuant to the terms of its lease agreement for the Company’s headquarters, the Company obtained a letter of credit in the amount of approximately $182,000 as security on the lease obligation. The letter of credit is listed as restricted cash on the Company’s consolidated balance sheets.

Short-term leases are leases having a term of twelve months or less. The Company recognizes short-term leases on a straight-line basis and does not record a related lease asset or liability for such leases.

The following is a maturity analysis of the annual undiscounted cash flows of the operating lease liabilities as of March 31, 2021 (in thousands):

Year ended:
December 31, 2021	$	401
December 31, 2022		496
Total minimum lease payments		897
Less imputed interest		(69	)
Total	$	828

	Three Months Ended March 31,
	2020			2021
Lease cost:
Operating lease cost	$	122		$	122
Short-term lease cost		-			-
Sublease income		(12	)		(13	)
Total lease cost	$	110		$	109
Other information
Cash paid for amounts included in the measurement of lease liabilities	$	173		$	141
Operating cash flows from operating leases	$	(10	)	$	(14	)
Weighted-average remaining lease term - operating leases	2.7 years			1.7 years
Weighted-average discount rate - operating leases		10.1	%		10.1	%

In February 2018, the Company signed a sublease agreement for its facility located in Lexington, Massachusetts. The lease commenced on April 1, 2018 and has an initial term of three years with an extension term through December 2022. In February 2020, the sublease was extended until December 31, 2022.

Research and Development Agreements

As part of the Company’s research and development efforts, the Company enters into research and development agreements with certain companies. These agreements contain varying terms and provisions which include fees and milestones to be paid by the Company. Some of these agreements also contain provisions which require the Company to make payments for exclusivity in the development of products in the area of loop diuretics.

Contingencies

The Company follows subtopic 450-20 of the FASB Accounting Standards Codification to report accounting for contingencies.

Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed. Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed.

Due to the discontinuation of use of the sc2Wear Infusor, the Company has received notice of termination costs related to the program. The Company has accrued all costs for which it either believes it is contractually liable or for which the Company has negotiated settlement agreements in good faith. However, certain of the Company’s vendors have claimed or billed for additional costs for which the Company believes it is not obligated. At this time, the Company estimates that additional termination costs, if any, will be immaterial to the Company’s financial statements.

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our financial statements and related notes thereto included elsewhere in this Quarterly Report on Form 10-Q (“Quarterly Report”) and our audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2020 (the “Annual Report”) filed with the Securities and Exchange Commission (the “SEC”) on March 23, 2021. Some of the information contained in this discussion and analysis or set forth elsewhere in this Quarterly Report, including information with respect to our plans and strategy for our business, includes forward looking statements that involve risks and uncertainties. As a result of many factors, including those factors set forth in the “Risk Factors” section in our Annual Report and in this Quarterly Report, our actual results could differ materially from the results described in or implied by, the forward-looking statements contained in the following discussion and analysis.

OVERVIEW

We are a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. Our strategy is designed to enable the subcutaneous administration of therapies that have previously been limited to intravenous, or IV, delivery. By moving delivery away from the high-cost healthcare settings typically required for IV administration, we believe our technology has the potential to reduce overall healthcare costs and advances the quality and convenience of care. Our lead product candidate, FUROSCIX, consists of our novel formulation of furosemide delivered via an on-body infusor and is under development for treatment of congestion in patients with worsening heart failure who display reduced responsiveness to oral diuretics and do not require hospitalization.

We resubmitted our new drug application, or NDA, for FUROSCIX, with the U.S. Food and Drug Administration, or FDA, on June 30, 2020. The resubmission was a response to a Complete Response Letter, or CRL, from the FDA with respect to our NDA submitted in August 2017, which indicated that, among other things, certain device modifications to our infusor were required. Based on our interactions with the FDA, which required device modifications necessary to advance FUROSCIX using its then current technology, we decided to transition to our next generation device. The resubmission incorporated our next generation device which is being developed through a partnership with West Pharmaceutical Services, Inc., or West, using its proprietary, wearable, SmartDose® drug delivery system (SmartDose is a registered trademark of West Pharma. Services IL, Ltd., a subsidiary of West, in the United States and other jurisdictions).

On July 23, 2020, the FDA accepted the resubmission of our NDA and we were given a Prescription Drug User Fee Act, or PDUFA, target action date of December 30, 2020; however, on December 3, 2020, we received a CRL from the FDA, in which, among other things, the FDA raised questions related to testing, labeling and features of the combination product unrelated to the drug constituent. The FDA also indicated that they needed to conduct pre-approval inspections at three of our third-party manufacturing facilities. No clinical deficiencies were noted. On January 28, 2021, we had a Type A meeting with the FDA to discuss the issues described in the CRL and steps required for the resubmission of the NDA for FUROSCIX. Based on the meeting, we anticipate the FDA will still need to conduct pre-approval inspections at three of our third-party manufacturing facilities. We are still in discussion with the FDA regarding testing requirements of the West SmartDose Gen II on-body infusor and we have a Type C meeting scheduled in June to discuss this in detail. Pending resolution of the testing plan and assuming device modifications are not required, we anticipate resubmitting our NDA in the fall of 2021.

We continued enrollment in FREEDOM-HF, a prospective clinical trial evaluating overall and heart failure-related costs for subjects treated with FUROSCIX outside the hospital for 30 days post-discharge from the emergency department compared to patients receiving intravenous furosemide in the hospital setting. We are expecting a top-line readout in the third quarter of 2021 to support the planned commercial launch of FUROSCIX, if approved.

Enrollment has commenced in AT HOME-HF, a multicenter, randomized, open label, controlled study in heart failure patients with worsening signs and symptoms of congestion requiring augmentation in diuretic therapy outside of an acute care setting. The objective of this pilot study is to evaluate the effectiveness and safety of FUROSCIX versus continued medical therapy to inform a larger, pivotal clinical trial.

We have funded our operations from inception through March 31, 2021 primarily through the sale of shares of our common stock and, prior to that, through the private placement of our preferred stock and the incurrence of debt. We do not have any products approved for sale and have not generated any revenue from product sales.

As of March 31, 2021, we had an accumulated deficit of $168.8 million. We expect to continue to incur net losses for the foreseeable future as we develop the infrastructure to commercialize our products, if approved, in the United States, including building our sales and marketing organization, continuing research and development efforts, engaging in scale-up manufacturing and seeking regulatory approval for new product candidates and enhancements. We will need additional funding to pay expenses related to our operating activities, including selling, general and administrative expenses and research and development expenses. Adequate funding may not be available to us on acceptable terms, or at all. Our failure to obtain sufficient funds on acceptable terms when needed could have a material adverse effect on our business, results of operations or financial condition.

IMPACT OF COVID-19

A new strain of novel coronavirus which causes a severe respiratory disease (“COVID-19”) was identified in 2019, and subsequently declared a pandemic by the World Health Organization, affecting the populations of the United States as well as the rest of the world. In response to the pandemic, we transitioned our workforce to work from home in March 2020. In July 2020, we opened our offices for limited access to employees integrating all recommendations for workplace safety, including appropriate protocols to ensure social-distancing. The health of our employees remains a top priority and we are continuing to monitor the impact of COVID-19 including the pace of vaccinations and the emergence of new and more contagious strains of the virus and government regulations.

To date, the third parties that perform our manufacturing, assembly, packaging and testing of our products have generally remained operational. The extent of the impact of the COVID-19 pandemic on the timing of our ability to resubmit the FUROSCIX NDA, the FDA’s subsequent review of the FUROSCIX NDA or possible delays in enrolling patients to our upcoming or recently initiated trials and our operational and financial performance will depend on future developments, including the duration, severity and spread of the pandemic, related restrictions on travel and transportation, the impact of new strains of the virus, the effectiveness and availability of vaccines and other actions that may be taken by governmental authorities, including the ability of the FDA to inspect facilities required for approval of our NDA, the impact to the business of our suppliers or customers, and other items identified under “Risk Factors” in our Annual Report on Form 10-K, all of which are uncertain and cannot be predicted. An extended period of global supply chain and economic disruption could materially affect our business, results of operations, access to sources of liquidity and financial condition.

COMPONENTS OF OUR RESULTS OF OPERATIONS

Research and Development Expenses

Research and development, or R&D, expenses consist of the cost of engineering, clinical trials, regulatory and medical affairs and quality assurance associated with developing our proprietary technology and product candidates. R&D expenses consist primarily of:

•

employee-related expenses, including salaries, benefits, travel expense and stock-based compensation expense;

•

cost of outside consultants who assist with technology development, regulatory affairs, clinical trials and medical affairs, and quality assurance;

•

cost of clinical trial activities performed by third parties; and

•

cost of facilities and supplies used for internal research and development and clinical activities.

We expense R&D costs as incurred. Given the emphasis to date on our lead product candidate FUROSCIX, our R&D expenses have not been allocated on a program-specific basis. In the future, we expect R&D expenses to increase in absolute dollars as we continue to develop new products and enhance existing products and technologies. We anticipate that our expenses will increase significantly as we:

•

pursue regulatory approval of FUROSCIX incorporating the SmartDose drug delivery system;

•

continue to advance our pipeline programs beyond FUROSCIX;

•

continue our current research and development activity;

•

seek to identify additional research programs and additional product candidates;

•

initiate preclinical testing and clinical trials for any product candidates we identify and develop, maintain, expand and protect our intellectual property portfolio; and

•

hire additional research, clinical and scientific personnel.

General and Administrative Expenses

General and administrative, or G&A, expenses consist of employee-related expenses, including salaries, benefits, travel expense and stock-based compensation expense for personnel in executive, finance, commercial, human resources, facility operations and administrative functions. Other G&A expenses include pre-approval promotional activities, marketing, conferences and trade shows, professional services fees, including legal, audit and tax fees, insurance costs, general corporate expenses and allocated facilities-related expenses.

If we receive FDA approval for FUROSCIX incorporating the next generation SmartDose drug delivery system, we anticipate that our G&A expenses will increase as we continue to build our corporate and commercial infrastructure to support the development and commercial launch of FUROSCIX in the United States.

Results of Operations

Comparison of Three Months Ended March 31, 2020 and 2021

The following table summarizes our results of operations for the three months ended March 31, 2020 and 2021 (in thousands):

	Three Months Ended March 31,						Increase
	2020			2021			(Decrease)
Operating expenses:
Research and development	$	4,146		$	4,009		$	(137	)
General and administrative		2,503			2,732			229
Total operating expenses		6,649			6,741			92
Loss from operations		(6,649	)		(6,741	)		92
Other (expense) income		(31	)		255			286
Interest income		224			20			(204	)
Interest expense		(636	)		(636	)		-
Net loss	$	(7,092	)	$	(7,102	)	$	10

Research and development expenses. R&D expenses were $4.0 million for the three months ended March 31, 2021, compared to $4.1 million for the three months ended March 31, 2020. The decrease of $0.1 million was primarily attributable to a decrease of $1.6 million in device development costs. The decrease was partially offset by a $0.5 million increase in clinical study activity and clinical consulting, a $0.4 million increase in employee-related costs, a $0.3 million increase in pharmaceutical development costs, and a $0.2 million increase in contract services for medical affairs.

General and administrative expenses. G&A expenses were $2.7 million for the three months ended March 31, 2021, compared to $2.5 million for the three months ended March 31, 2020. The increase of $0.2 million was primarily attributable to a $0.3 million increase in employee-related costs and a $0.1 million increase in director and officer’s insurance. The increase was partially offset by a $0.2 million decrease in legal costs.

Other (expense) income. Other income was $0.3 million for the three months ended March 31, 2021, compared to other expense of $31,000 for the three months ended March 31, 2020. The increase in income of $0.3 million was primarily attributable to the recovery of fees associated with a post-employment matter.

Interest income. Interest income was $20,000 for the three months ended March 31, 2021, compared to $0.2 million for the three months ended March 31, 2020. The decrease of $0.2 million was primarily attributable to lower interest rates on our financial instruments.

Interest expense. Interest expense was $0.6 million for the three months ended March 31, 2021 and for the three months ended March 31, 2020. Interest expense consists of interest on the $20.0 million term loan with SLR Investment Corp. (f/k/a Solar Capital Ltd.) and Silicon Valley Bank.

LIQUIDITY AND CAPITAL RESOURCES

Overview

We have funded our operations from inception through March 31, 2021 primarily through the sale of shares of our common stock and, prior to that, through the private placement of our preferred stock and the incurrence of debt. As of March 31, 2021, we had received net cash proceeds of $92.7 million from our initial public offering, $56.7 million from sales of our preferred stock, $18.8 million from borrowings under our term loan, $13.5 million from sales of convertible notes, $50.2 million from our public offering in 2020 and $14.4 million from the sale of common stock in our 2019 at-the-market offering. As of March 31, 2021, we had cash, cash equivalents and restricted cash of $76.0 million and short-term investments of $20.5 million.

On March 23, 2021, we entered into the 2021 ATM Agreement with Cowen to sell shares of our common stock, from time to time, with aggregate gross sales proceeds of up to $50.0 million, through an at-the-market equity offering program under which Cowen will act as our sales agent. As of March 31, 2021, we had received no proceeds from the sale of shares of common stock pursuant to the 2021 ATM Agreement.

We expect to incur substantial additional expenditures in the near future to support our ongoing activities and our plans to obtain regulatory approval for FUROSCIX incorporating the next generation SmartDose drug delivery system. We believe our existing unrestricted cash is sufficient to fund our operations through at least the next 12 months from the date of this quarterly report. We expect our costs and expenses to increase in the future as we prepare for and, if approved, commence U.S. commercialization of FUROSCIX, including the development of a direct sales force, and as we continue to make substantial expenditures on research and development, including to increase our manufacturing capacity and for conducting clinical trials of our product candidates.

Additionally, we will incur additional costs as a result of operating as a public company. Our future capital requirements will depend on many factors, including:

•

the time and expense required to resubmit the NDA for FUROSCIX;

•

the potential FDA approval of FUROSCIX;

•

the costs and expenses of establishing our U.S. sales and marketing infrastructure;

•

the degree of success we experience in commercializing FUROSCIX, if approved;

•

the revenue generated by sales of FUROSCIX, if approved, and other products that may be approved;

•

the pricing and reimbursement of FUROSCIX, if approved, and of other product candidates that may be approved;

•

the costs, timing and outcomes of clinical trials and regulatory reviews associated with our product candidates;

•

the emergence of competing or complementary technological developments;

•

the extent to which FUROSCIX, if approved, is adopted by the healthcare community;

•

the number and types of future products we develop and commercialize;

•

the costs of preparing, filing and prosecuting patent applications and maintaining, enforcing and defending intellectual property-related claims;

•

the impact of COVID-19 on our operations; and

•

the extent and scope of our general and administrative expenses.

Additional financing may not be available on a timely basis on terms acceptable to us, or at all. We may raise funds in equity, royalty-based or debt financings or enter into additional credit facilities in order to access funds for our capital needs. If we raise additional funds through further issuances of equity or convertible debt securities, our existing stockholders could suffer significant dilution in their percentage ownership of our company, and any new equity securities we issue could have rights, preferences and privileges senior to those of holders of our common stock. If we raise additional funds through royalty-based financing arrangements, we will likely agree to relinquish rights to potentially valuable future revenue streams and may agree to covenants that restrict our operations or strategic flexibility. Any debt financing obtained by us in the future would cause us to incur additional debt service expenses and could include restrictive covenants relating to our capital raising activities and other financial and operational matters, which may make it more difficult for us to obtain additional capital and pursue business opportunities. If we are unable to obtain adequate financing or financing on terms satisfactory to us when we require it, we may terminate or delay the development of one or more of our products, delay clinical trials necessary to market our products, or delay establishment or expansion of sales and marketing capabilities or other activities necessary to commercialize our products.

CASH FLOWS

The following table summarizes our sources and uses of cash for each of the periods presented:

	Three Months Ended March 31,
(in thousands)	2020			2021
Net cash (used in) provided by:
Operating activities	$	(7,743	)	$	(8,615	)
Investing activities		-			12,705
Financing activities		10,458			(72	)
Net increase in cash, cash equivalents and restricted cash	$	2,715		$	4,018

Net Cash Used in Operating Activities

During the three months ended March 31, 2021, net cash used in operating activities was $8.6 million, consisting primarily of a net loss of $7.1 million and an increase in net operating assets of $2.3 million. This was offset by non-cash charges of $0.8 million,

which primarily consisted of depreciation, amortization related to our right of use leased assets, stock-based compensation expense, non-cash interest expense related to amortization of debt discount associated with the 2019 Loan Agreement and accretion of discount on investments. The increase in net operating assets is related to accrued expenses for employee-related and device development costs.

During the three months ended March 31, 2020, net cash used in operating activities was $7.7 million, consisting primarily of a net loss of $7.1 million. This was offset by non-cash charges of $0.8 million and a $1.4 million increase in net operating assets. The non-cash charges primarily consisted of depreciation, amortization related to our right of use leased assets, stock-based compensation expense, non-cash interest expense related to amortization of debt discount associated with the 2019 Loan Agreement and the fair value adjustment to the derivative liability. The increase in net operating assets related to accrued expenses for device development costs and materials.

Net Cash Provided by Investing Activities

During the three months ended March 31, 2021, net cash provided by investing activities was $12.7 million, consisting of maturities and purchases of short-term investments.

There was no cash from investing activities during the three months ended March 31, 2020.

Net Cash Provided by (Used in) Financing Activities

During the three months ended March 31, 2021, net cash used in financing activities was $72,000, consisting primarily of tax obligations on the settlement of restricted stock units, offset by stock option exercises.

During the three months ended March 31, 2020, net cash provided by financing activities was $10.5 million, consisting primarily of net proceeds of $10.4 million from the 2019 at-the-market offering and stock option exercises, offset by tax obligations on the settlement of restricted stock units.

OFF-BALANCE SHEET ARRANGEMENTS

We currently have no off-balance sheet arrangements.

CONTRACTUAL OBLIGATIONS

There were no material changes in our commitments under contractual obligations, as disclosed in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020, filed with the SEC on March 23, 2021.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

Management’s discussion and analysis of our financial condition and results of operations is based on our financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles, or U.S. GAAP. The preparation of these financial statements requires us to make estimates and assumptions for the reported amounts of assets, liabilities, revenue, expenses and related disclosures. Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions and any such differences may be material. Our critical accounting policies are more fully described under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies and Estimates” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020, filed with the SEC on March 23, 2021.

JOBS ACT ACCOUNTING ELECTION

In April 2012, the Jumpstart Our Business Startups Act of 2012, or JOBS Act, was enacted. Section 107 of the JOBS Act provides that an emerging growth company can take advantage of an extended transition period for complying with new or revised accounting standards. Thus, an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected not to avail ourselves of this extended transition period and, as a result, we adopt new or revised accounting standards on the relevant dates on which adoption of such standards is required for other public companies. This election is irrevocable.

Item 3.

Quantitative and Qualitative Disclosures About Market Risk.

We are exposed to market risks related to changes in foreign currency exchange rates and interest rates.

We contract with vendors in foreign countries. As such, we have exposure to adverse changes in exchange rates of foreign currencies, principally the Swiss franc and the Euro, associated with our foreign transactions. We believe this exposure to be immaterial. We currently do not hedge against this exposure to fluctuations in exchange rates.

Our exposure to market risk also relates to interest rate sensitivity, which is affected by changes in the general level of U.S. interest rates. As of March 31, 2021, our aggregate outstanding indebtedness was $20.0 million, which bears interest at the rate at the higher of (i) LIBOR plus 7.95% or (ii) 10.18%. Due to the short-term duration and variable rate of our indebtedness, an immediate 100 basis point change in interest rates would not have a material effect on the fair market value of our debt instruments.

Item 4.

Controls and Procedures.

Our management, with the participation of our principal executive officer and our principal financial officer, evaluated, as of the end of the period covered by this Quarterly Report on Form 10-Q, the effectiveness of our disclosure controls and procedures. Based on that evaluation of our disclosure controls and procedures as of March 31, 2021, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures as of such date are effective at the reasonable assurance level. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by the company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive officer and principal financial and accounting officer, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and our management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

There were no changes in our internal control over financial reporting during the three months ended March 31, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II — OTHER INFORMATION

Item 1.

Legal Proceedings

From time to time, we may be subject to legal proceedings and claims in the ordinary course of business. We are not currently aware of any such proceedings or claims that we believe will have, individually or in the aggregate, a material adverse effect on our business, financial condition or results of operations.

Item 1A.

Risk Factors

Investing in our common stock involves a high degree of risk. Information regarding risk factors appears in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2020, which was filed with the SEC on March 23, 2021. There have been no material changes from the risk factors previously disclosed in that Annual Report on Form 10-K.

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3.

Defaults Upon Senior Securities

None.

Item 4.

Mine Safety Disclosures

Not applicable.

Item 5.

Other Information

None.

Item 6.

Exhibits

EXHIBIT INDEX

Exhibit Number		Description




31.1*		Certification of Principal Executive Officer and Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1†		Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS*		XBRL Instance Document

101.SCH*		XBRL Taxonomy Extension Schema Document

101.CAL*		XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF*		XBRL Taxonomy Extension Definition Linkbase Document

101.LAB*		XBRL Taxonomy Extension Label Linkbase Document

101.PRE*		XBRL Taxonomy Extension Presentation Linkbase Document

*	Filed herewith.

†

This certification will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act, except to the extent specifically incorporated by reference into such filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	SCPHARMACEUTICALS INC.

Date: May 12, 2021	By:	/s/ John H. Tucker
		John H. Tucker
		President and Chief Executive Officer (Principal Executive Officer and Principal Financial Officer)

EX-31.1 2 scph-ex311_6.htm EX-31.1 scph-ex311_6.htm

Exhibit 31.1

Certification

I, John H. Tucker, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q for the period ended March 31, 2021 of SCPHARMACEUTICALS INC.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. (Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313);

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 12, 2021			/s/ John H. Tucker
			John H. Tucker
			President and Chief Executive Officer
			(Principal Executive Officer and Principal Financial Officer)

EX-32.1 3 scph-ex321_7.htm EX-32.1 scph-ex321_7.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report on Form 10-Q of scPharmaceuticals Inc. (the “Company”) for the period ended March 31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John H. Tucker, President and Chief Executive Officer (Principal Executive Officer and Principal Financial Officer) hereby certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to my knowledge:

1)	the Report which this statement accompanies fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 12, 2021			/s/ John H. Tucker
			John H. Tucker
			President and Chief Executive Officer
			(Principal Executive Officer and Principal Financial Officer)

EX-101.INS 4 scph-20210331.xml XBRL INSTANCE DOCUMENT xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure 0001604950 2021-01-01 2021-03-31 0001604950 2021-05-12 0001604950 2020-12-31 0001604950 2021-03-31 0001604950 2020-01-01 2020-03-31 0001604950 us-gaap:CommonStockMember 2020-12-31 0001604950 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001604950 us-gaap:RetainedEarningsMember 2020-12-31 0001604950 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001604950 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001604950 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001604950 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001604950 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0001604950 us-gaap:CommonStockMember 2021-03-31 0001604950 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001604950 us-gaap:RetainedEarningsMember 2021-03-31 0001604950 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0001604950 us-gaap:CommonStockMember 2019-12-31 0001604950 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001604950 us-gaap:RetainedEarningsMember 2019-12-31 0001604950 2019-12-31 0001604950 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001604950 scph:AtTheMarketOfferingMember us-gaap:CommonStockMember 2020-01-01 2020-03-31 0001604950 scph:AtTheMarketOfferingMember us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001604950 scph:AtTheMarketOfferingMember 2020-01-01 2020-03-31 0001604950 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0001604950 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001604950 us-gaap:CommonStockMember 2020-03-31 0001604950 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001604950 us-gaap:RetainedEarningsMember 2020-03-31 0001604950 2020-03-31 0001604950 2020-09-30 0001604950 us-gaap:LetterOfCreditMember 2021-03-31 0001604950 scph:StockOptionsToPurchaseCommonStockMember 2020-01-01 2020-03-31 0001604950 scph:StockOptionsToPurchaseCommonStockMember 2021-01-01 2021-03-31 0001604950 scph:UnvestedRestrictedStockUnitsMember 2020-01-01 2020-03-31 0001604950 scph:UnvestedRestrictedStockUnitsMember 2021-01-01 2021-03-31 0001604950 us-gaap:USTreasurySecuritiesMember 2021-03-31 0001604950 us-gaap:CorporateDebtSecuritiesMember 2021-03-31 0001604950 us-gaap:CommercialPaperMember 2021-03-31 0001604950 us-gaap:OfficeEquipmentMember 2021-01-01 2021-03-31 0001604950 us-gaap:FurnitureAndFixturesMember 2021-01-01 2021-03-31 0001604950 us-gaap:ComputerEquipmentMember 2021-01-01 2021-03-31 0001604950 us-gaap:LeaseholdImprovementsMember 2021-01-01 2021-03-31 0001604950 us-gaap:OfficeEquipmentMember 2020-12-31 0001604950 us-gaap:OfficeEquipmentMember 2021-03-31 0001604950 us-gaap:FurnitureAndFixturesMember 2020-12-31 0001604950 us-gaap:FurnitureAndFixturesMember 2021-03-31 0001604950 us-gaap:ComputerEquipmentMember 2020-12-31 0001604950 us-gaap:ComputerEquipmentMember 2021-03-31 0001604950 us-gaap:LeaseholdImprovementsMember 2020-12-31 0001604950 us-gaap:LeaseholdImprovementsMember 2021-03-31 0001604950 us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001604950 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001604950 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001604950 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001604950 us-gaap:FairValueInputsLevel1Member us-gaap:USTreasurySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001604950 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001604950 us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001604950 us-gaap:CommercialPaperMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001604950 us-gaap:FairValueInputsLevel2Member us-gaap:CommercialPaperMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001604950 us-gaap:FairValueMeasurementsRecurringMember 2021-03-31 0001604950 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-03-31 0001604950 us-gaap:MortgageBackedSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2021-03-31 0001604950 us-gaap:FairValueInputsLevel1Member us-gaap:MortgageBackedSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2021-03-31 0001604950 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2021-03-31 0001604950 us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2021-03-31 0001604950 us-gaap:CommercialPaperMember us-gaap:FairValueMeasurementsRecurringMember 2021-03-31 0001604950 us-gaap:FairValueInputsLevel2Member us-gaap:CommercialPaperMember us-gaap:FairValueMeasurementsRecurringMember 2021-03-31 0001604950 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-03-31 0001604950 scph:TwoThousandSeventeenLoanAgreementMember scph:SLRInvestmentCorpAndSiliconValleyBankMember 2017-05-31 0001604950 scph:TwoThousandSeventeenLoanAgreementMember scph:SLRInvestmentCorpAndSiliconValleyBankMember 2017-05-01 2017-05-31 0001604950 scph:SLRInvestmentCorpAndSiliconValleyBankMember scph:TwoThousandNineteenLoanAgreementMember 2019-09-30 0001604950 scph:SLRInvestmentCorpAndSiliconValleyBankMember scph:TwoThousandNineteenLoanAgreementMember 2019-09-01 2019-09-30 0001604950 scph:SLRInvestmentCorpAndSiliconValleyBankMember scph:TwoThousandSeventeenLoanAgreementMember 2019-09-01 2019-09-30 0001604950 scph:SLRInvestmentCorpAndSiliconValleyBankMember us-gaap:LondonInterbankOfferedRateLIBORMember scph:TwoThousandNineteenLoanAgreementMember 2021-01-01 2021-03-31 0001604950 scph:SLRInvestmentCorpAndSiliconValleyBankMember scph:TwoThousandNineteenLoanAgreementMember 2021-01-01 2021-03-31 0001604950 scph:SLRInvestmentCorpAndSiliconValleyBankMember scph:TwoThousandNineteenLoanAgreementMember srt:MinimumMember 2021-03-31 0001604950 scph:SLRInvestmentCorpAndSiliconValleyBankMember scph:TwoThousandNineteenLoanAgreementMember 2021-03-31 0001604950 scph:SLRInvestmentCorpAndSiliconValleyBankMember scph:TwoThousandNineteenLoanAgreementMember 2020-01-01 2020-03-31 0001604950 scph:SLRInvestmentCorpAndSiliconValleyBankMember scph:TwoThousandNineteenLoanAgreementMember srt:MaximumMember 2021-01-01 2021-03-31 0001604950 scph:SLRInvestmentCorpAndSiliconValleyBankMember scph:TwoThousandNineteenLoanAgreementMember srt:MinimumMember 2021-01-01 2021-03-31 0001604950 scph:TwoThousandNineteenLoanAgreementMember scph:SLRInvestmentCorpAndSiliconValleyBankMember 2021-03-31 0001604950 scph:JefferiesLLCMember us-gaap:CommonStockMember srt:MaximumMember scph:TwoThousandNineteenATMAgreementMember 2019-08-23 0001604950 scph:TwoThousandNineteenATMAgreementMember scph:JefferiesLLCMember us-gaap:CommonStockMember 2019-08-23 2019-08-23 0001604950 scph:TwoThousandNineteenATMAgreementMember scph:LegalAccountingAndOtherCostsMember 2019-08-23 2019-08-23 0001604950 scph:TwoThousandNineteenATMAgreementMember scph:JefferiesLLCMember us-gaap:CommonStockMember 2020-01-01 2020-03-31 0001604950 scph:TwoThousandNineteenATMAgreementMember scph:JefferiesLLCMember us-gaap:CommonStockMember srt:WeightedAverageMember 2020-03-31 0001604950 scph:TwoThousandNineteenATMAgreementMember us-gaap:AdditionalPaidInCapitalMember scph:LegalAccountingAndOtherCostsMember 2020-01-01 2020-03-31 0001604950 scph:CowenAndCompanyLLCMember us-gaap:CommonStockMember srt:MaximumMember scph:TwentyTwentyOneATMAgreementMember 2021-03-23 0001604950 scph:CowenAndCompanyLLCMember us-gaap:CommonStockMember srt:MaximumMember scph:TwentyTwentyOneATMAgreementMember 2021-03-23 2021-03-23 0001604950 scph:CowenAndCompanyLLCMember us-gaap:CommonStockMember scph:TwentyTwentyOneATMAgreementMember 2021-01-01 2021-03-31 0001604950 scph:TwoThousandSeventeenStockPlanMember 2021-01-01 2021-03-31 0001604950 scph:TwoThousandFourteenStockPlanMember 2021-01-01 2021-03-31 0001604950 scph:TwoThousandFourteenStockPlanMember 2021-03-31 0001604950 scph:TwoThousandSeventeenStockPlanMember 2021-03-31 0001604950 scph:TwoThousandSeventeenStockPlanMember srt:MinimumMember 2021-01-01 2021-03-31 0001604950 scph:TwoThousandSeventeenStockPlanMember srt:MaximumMember 2021-01-01 2021-03-31 0001604950 scph:TwoThousandSeventeenStockPlanMember us-gaap:RestrictedStockUnitsRSUMember 2021-03-31 0001604950 srt:MinimumMember 2020-01-01 2020-03-31 0001604950 srt:MinimumMember 2021-01-01 2021-03-31 0001604950 srt:MaximumMember 2020-01-01 2020-03-31 0001604950 srt:MaximumMember 2021-01-01 2021-03-31 0001604950 us-gaap:PerformanceSharesMember 2021-01-01 2021-03-31 0001604950 us-gaap:RestrictedStockUnitsRSUMember 2020-12-31 0001604950 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-03-31 0001604950 us-gaap:RestrictedStockUnitsRSUMember 2021-03-31 0001604950 us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-03-31 0001604950 us-gaap:ResearchAndDevelopmentExpenseMember 2021-01-01 2021-03-31 0001604950 us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-03-31 0001604950 us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-03-31 0001604950 scph:LeaseAgreementRequireStandbyLetterOfCreditMember us-gaap:LetterOfCreditMember 2021-03-31 0001604950 scph:StraightLineBasisMember 2021-03-31 0001604950 2018-02-01 2018-02-28 10-Q false 2021-03-31 2021 Q1 SCPH SCPHARMACEUTICALS INC. 0001604950 --12-31 Non-accelerated Filer Yes true true true false Yes Common stock, par value $0.0001 NASDAQ 001-38293 DE 46-5184075 2400 District Avenue Suite 310 Burlington MA 01803 617 517-0730 true false 27355454

71819000

75837000

33276000

20490000

2610000

2637000

121000

102000

107826000

99066000

182000

93000

85000

815000

717000

132000 243000

109048000

100293000

1666000

753000

4787000

3585000

2408000

4838000

460000

472000

9321000

9648000

16858000

14515000

480000

356000

219000

259000

26878000

24778000

3000

243830000

244279000

-161664000

-168766000

1000

-1000

82170000

75515000

109048000

100293000

0.0001

10000000

0.0001

150000000

27355453

27325959

27355453

27325959

4146000

4009000

2503000

2732000

6649000

6741000

-6649000

-6741000

-31000

255000

224000

20000

636000

-7092000

-7102000

-0.35

-0.26

20218473

27336724

-2000

-7092000

-7104000

27325959

3000

243830000

-161664000

1000

-7102000

2500

9000

26994

-81000

521000

-2000

27355453

3000

244279000

-168766000

-1000

19418955

2000

180818000

-129455000

51365000

-7092000

1502892

10253000

30143

154000

29890

-84000

508000

20981880

2000

191649000

-136547000

55104000

8000

87000

98000

79000

508000

521000

121000

127000

30000

720000

119000

-685000

-2227000

-7743000

-8615000

16700000

3995000

12705000

10388000

154000

9000

84000

81000

10458000

-72000

2715000

4018000

72806000

72001000

75521000

76019000

518000

597000

42000 135000

1. Description of Business and Basis of Presentation Description of Business scPharmaceuticals LLC was formed as a limited liability company under the laws of the State of Delaware on February 19, 2013. On March 24, 2014, scPharmaceuticals LLC was converted to a Delaware corporation and changed its name to scPharmaceuticals Inc. (“the Company”). The Company is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The Company’s strategy is designed to enable the subcutaneous administration of therapies that have previously been limited to intravenous (“IV”) delivery. The Company’s headquarters and primary place of business is Burlington, Massachusetts. Basis of Presentation The accompanying condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and have been prepared on a basis which assumes that the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. The condensed consolidated financial statements reflect the operations of the Company and its wholly-owned subsidiary, scPharmaceuticals Securities Corporation. Certain information and disclosures normally included in financial statements in accordance with U.S. GAAP have been condensed or omitted. Accordingly, these condensed consolidated financial statements should be read in conjunction with the Company’s audited financial statements and related notes for the year ended December 31, 2020 included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) on March 23, 2021. The Company has determined that it operates in one segment. The accompanying condensed consolidated balance sheet as of March 31, 2021, the condensed consolidated statements of operations and comprehensive loss and stockholders’ equity for the three months ended March 31, 2020 and 2021 and condensed consolidated statements of cash flows for the three months ended March 31, 2020 and 2021 are unaudited. The unaudited condensed consolidated financial statements have been prepared on a basis consistent with that used to prepare the Company’s audited annual financial statements and include, in the opinion of management, adjustments, consisting of normal recurring items, necessary for the fair statement of the condensed consolidated financial statements. The operating results for the three months ended March 31, 2021 are not necessarily indicative of the results expected for the full year ending December 31, 2021. <p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;color:#212529;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Liquidity <p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#212529;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of March 31, 2021, the Company had an accumulated deficit of approximately $168.8 million. Management expects to continue to incur operating losses for the foreseeable future. The Company has financed its operations to date from proceeds from the sale of common stock, preferred stock and the incurrence of debt. <p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of March 31, 2021, the Company had cash, cash equivalents, restricted cash, and short-term investments of $96.5 million. The Company believes that its existing cash, cash equivalents, restricted cash and short-term investments will be sufficient to meet its cash commitments for at least the next 12 months after the date that the interim condensed consolidated financial statements are issued.

3. Net Loss per Share Net Loss per Share Attributable to Common Stockholders The following table sets forth the computation of basic and diluted net loss per share of common stock (in thousands, except share and per share data):   <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended March 31,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;"> Net loss</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,092</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> )</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,102</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> )</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;"> Weighted-average shares used in computing net loss per share</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,218,473</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,336,724</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;"> Net loss per share, basic and diluted</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.35</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> )</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.26</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> )</td> </tr> </table></div>   The Company’s potentially dilutive securities, which include stock options and unvested restricted stock units, have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share. Therefore, the weighted average number of common shares outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same. The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect.   <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended March 31,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> Stock options to purchase common stock</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,058,355</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,805,029</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> Unvested restricted stock units</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">122,700</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,250</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;"> Total</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,181,055</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,847,279</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> </tr> </table></div>

7. Fair Value of Financial Instruments The Financial Accounting Standards Board (“FASB”) Accounting Standard Codification (“ASC”) Topic, Fair Value Measurements and Disclosures (“ASC 820”), provides a fair value hierarchy, which classifies fair value measurements based on the inputs used in measuring fair value. Observable inputs are inputs that market participants would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions about the inputs that market participants would use in pricing the asset or liability, and are developed based on the best information available in the circumstances. The fair value hierarchy applies only to the valuation inputs used in determining the reported fair value of the investments and is not a measure of the investment credit quality. The three levels of the fair value hierarchy are described below: Level 1—Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. Level 2—Valuations based on quoted prices for similar assets or liabilities in markets that are not active or for which all significant inputs are observable, either directly or indirectly. Level 3—Valuations that require inputs that reflect the Company’s own assumptions that are both significant to the fair value measurement and observable. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized in Level 3. A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. The carrying values of the Company’s cash and restricted cash, prepaid expenses and deposits approximate their fair values due to their short-term nature. The carrying value of the Company’s loan payable was considered a reasonable estimate of fair value because the Company’s interest rate is near current market rates for instruments with similar characteristics.   The following tables summarize the Company’s assets that are measured at fair value on a recurring basis and indicates the level of the fair value hierarchy utilized to determine such fair values (in thousands):   <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.82%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="14" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.92%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.82%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.22%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">TOTAL</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Quoted Prices <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">in Active <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Markets <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">(Level 1)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-top:solid 0.75pt #000000;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Significant <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Other <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Observable <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Inputs <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">(Level 2)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-top:solid 0.75pt #000000;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Significant <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Unobservable <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Inputs <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">(Level 3)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.82%;"> Assets:</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.22%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash equivalents</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.22%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70,797</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">68,798</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,999</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.22%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70,797</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">68,798</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,999</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.22%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.82%;"> United States Treasury securities</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.22%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,213</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,213</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.82%;"> Corporate debt securities</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.22%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,973</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,973</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.82%; border-bottom:solid 0.75pt transparent;"> Commercial paper</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.22%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,090</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,090</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Investments</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.22%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33,276</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,213</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,063</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.22%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.82%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.22%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">104,073</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">77,011</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,062</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.22%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.22%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="14" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.92%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">As of March 31, 2021</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.82%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.22%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">TOTAL</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Quoted Prices <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">in Active <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Markets <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">(Level 1)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-top:solid 0.75pt #000000;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Significant <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Other <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Observable <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Inputs <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">(Level 2)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-top:solid 0.75pt #000000;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Significant <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Unobservable <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Inputs <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">(Level 3)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.82%;"> Assets:</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.22%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash equivalents</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.22%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75,115</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75,115</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.22%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75,115</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75,115</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.22%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.82%;"> United States Treasury securities</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.22%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,706</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,706</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.82%;"> Corporate debt securities</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.22%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,892</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,892</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.82%; border-bottom:solid 0.75pt transparent;"> Commercial paper</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.22%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,892</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,892</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Investments</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.22%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,490</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,706</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,784</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.22%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.82%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.22%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">95,605</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">78,821</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,784</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.22%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> </table></div>

9. Stockholders’ Equity <p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2019 At-the-Market Issuance Sales Agreement <p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On August 23, 2019, the Company entered into an Open Market Sale AgreementSM (“2019 ATM Agreement”), with Jefferies LLC (“Jefferies”) with respect to an at-the-market offering program (the “2019 ATM Program”) under which the Company could offer and sell shares of its common stock (the “2019 ATM Shares”), having an aggregate offering price of up to $15.0 million through Jefferies as its sales agent. The offering and sale of 2019 ATM Shares were made pursuant to the Company’s shelf registration statement on Form S-3, which was declared effective by the SEC on February 11, 2019 (the “Registration Statement”). <p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company agreed to pay Jefferies a commission equal to 3.0% of the gross sales proceeds of such 2019 ATM Shares. The Company incurred $189,000 of legal, accounting and other costs to establish and activate the 2019 ATM program. <p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the three months ended March 31, 2020, the Company sold a total of 1,502,892 2019 ATM Shares under the 2019 ATM Agreement, in the open market, at a weighted average gross selling price of $7.13 per share for net proceeds of $10.4 million, which completed the program. The Company charged $135,000 in costs related to establishing and activating the program against additional paid in capital upon issuance of shares during the three months ended March 31, 2020. 2021 At-the-Market Issuance Sales Agreement On March 23, 2021, the Company entered into an Open Market Sale Agreement (the “2021 ATM Agreement”) with Cowen and Company, LLC (“Cowen”) with respect to an at-the-market offering program (the”2021 ATM Program”) under which the Company could offer and sell shares of its common stock (the “2021 ATM Shares”), having an aggregate offering price of up to $50.0 million through Cowen as its sales agent. The Company agreed to pay Cowen a commission up to 3.0% of the gross sales proceeds of such 2021 ATM Shares. As of March 31, 2021, the Company had received no proceeds from the sale of shares of common stock pursuant to the 2021 ATM Agreement.

10.  Stock-Based Compensation Stock Options The Company’s 2017 Stock Option and Incentive Plan (the “2017 Stock Plan”) became effective in November 2017, upon the closing of the Company’s initial public offering and will expire in October 2027. Under the 2017 Stock Plan, the Company may grant incentive stock options, non-statutory stock options, restricted stock awards, restricted stock units (“RSUs”) and other stock-based awards. The Company’s 2014 Stock Incentive Plan (the “2014 Stock Plan”) was terminated in November 2017 upon the completion of the Company’s initial public offering and no further options were granted under the 2014 Stock Plan. At March 31, 2021, there were 600,688 options outstanding under the 2014 Stock Plan.   As of March 31, 2021, there were 5,051,921 shares of the Company’s common stock authorized for issuance under the 2017 Stock Plan, including 359,651 options that have been forfeited from the 2014 Stock Plan. At March 31, 2021, there were 2,775,526 options available for issuance under the 2017 Stock Plan, 2,204,341 options outstanding and 42,250 RSUs outstanding. Awards granted under the 2017 Stock Plan have a term of ten years. Vesting of awards under the 2017 Stock Plan is determined by the board of directors, but, is generally over one to four-year terms. The fair value of options at date of grant was estimated using the Black-Scholes option-pricing model with the following assumptions:    <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">March 31,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> Risk-free interest rate</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td colspan="2" valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.93% - 1.71%</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td colspan="2" valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.50% - 0.72%</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> Expected dividend yield</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0%</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0%</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> Expected life</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td colspan="2" valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.5-6.6 years</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td colspan="2" valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.5-6.7 years</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> Expected volatility</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72%-73%</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72%-74%</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> Weighted-average grant date fair value</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.91</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.36</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> </table></div>   The following table summarizes information about stock option activity during the three months ended March 31, 2021 (in thousands, except share and per share data):    <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">NUMBER OF <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">SHARES</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">WEIGHTED- <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">AVERAGE <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">EXERCISE <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">PRICE</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">WEIGHTED- <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">AVERAGE <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">REMAINING <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">CONTRACTUAL <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">TERM</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">AGGREGATE <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">INTRINSIC <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">VALUE</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> Outstanding, December 31, 2020</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,224,913</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.26</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> Granted</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">785,406</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.84</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> Exercised</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,500</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> )</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.81</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;"> Forfeited</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(202,790</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> )</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.62</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;"> Outstanding, March 31, 2021</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,805,029</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.32</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.18</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,926</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> Vested and exercisable, March 31, 2021</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,125,780</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.66</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.64</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,222</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;"> Vested and expected to vest, March 31, 2021</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,013,825</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.26</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.76</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,541</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> </tr> </table></div>   Of the options granted during the three months ended March 31, 2021, 112,050 were performance-based options. Vesting of these performance-based options is contingent on the occurrence of certain regulatory and commercial milestones. The Company is recognizing the expense as straight-line over the expected performance achievement term.   The following table summarizes information about RSU activity during the three months ended March 31, 2021:   <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">RSUs</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">AVERAGE GRANT DATE FAIR VALUE (IN DOLLARS PER SHARE)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> Outstanding, December 31, 2020</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">80,450</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.25</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> Granted</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> Vested</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(38,200</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> )</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.25</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> Forfeited</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.88%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;"> RSUs outstanding at March 31, 2021</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,250</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.88%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.25</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> </tr> </table></div>   The number of RSUs vested includes shares of common stock withheld on behalf of employees to satisfy the minimum statutory tax withholding requirements.   Unrecognized compensation expense related to unvested options as of March 31, 2021 was $3.6 million and will be recognized over the remaining vesting periods of the underlying awards. The weighted-average period over which such compensation is expected to be recognized is 2.7 years. Unrecognized compensation expense related to unvested RSUs as of March 31, 2021 was $41,000 and will be recognized over the remaining vesting periods of the underlying awards. The weighted-average period over which such compensation is expected to be recognized is 1 year. The Company recorded stock-based compensation expense in the following expense categories of its accompanying condensed consolidated statements of operations and comprehensive loss for the three months ended March 31, 2020 and 2021 (in thousands):   <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended March 31,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> Research and development</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">144</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">226</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> General and administrative</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">364</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">295</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;"> Total</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">508</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">521</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> </tr> </table></div>

11. Commitments and Contingencies Operating Leases The Company leases office facilities and equipment under long-term, non-cancelable operating lease agreements. The leases expire at various dates through 2022 and do not include renewal options. Certain leases provide for increases in future minimum annual rental payments as defined in the lease agreements. The leases generally also include real estate taxes and common area maintenance charges in the annual rental payments. Pursuant to the terms of its lease agreement for the Company’s headquarters, the Company obtained a letter of credit in the amount of approximately $182,000 as security on the lease obligation. The letter of credit is listed as restricted cash on the Company’s consolidated balance sheets. Short-term leases are leases having a term of twelve months or less. The Company recognizes short-term leases on a straight-line basis and does not record a related lease asset or liability for such leases. The following is a maturity analysis of the annual undiscounted cash flows of the operating lease liabilities as of March 31, 2021 (in thousands):   <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;"> Year ended:</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;"> December 31, 2021</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">401</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;"> December 31, 2022</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">496</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;"> Total minimum lease payments</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">897</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;"> Less imputed interest</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(69</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> )</td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;"> Total</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">828</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> </tr> </table></div>   <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:64.84%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.42%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">March 31,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:64.84%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64.84%;"> Lease cost:</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64.84%;"> Operating lease cost</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">122</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">122</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64.84%;"> Short-term lease cost</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:64.84%; border-bottom:solid 0.75pt transparent;"> Sublease income</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(12</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> )</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(13</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> )</td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:64.84%; border-bottom:double 2.5pt transparent;"> Total lease cost</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">110</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">109</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64.84%;"> Other information</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64.84%;"> Cash paid for amounts included in the measurement of lease liabilities</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">173</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">141</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64.84%;"> Operating cash flows from operating leases</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(10</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> )</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(14</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> )</td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64.84%;"> Weighted-average remaining lease term - operating leases</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">  </td> <td colspan="2" valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.7 years</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.7 years</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64.84%;"> Weighted-average discount rate - operating leases</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.1</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> %</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.1</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> %</td> </tr> </table></div>   In February 2018, the Company signed a sublease agreement for its facility located in Lexington, Massachusetts. The lease commenced on April 1, 2018 and has an initial term of three years with an extension term through December 2022. In February 2020, the sublease was extended until December 31, 2022. Research and Development Agreements As part of the Company’s research and development efforts, the Company enters into research and development agreements with certain companies. These agreements contain varying terms and provisions which include fees and milestones to be paid by the Company. Some of these agreements also contain provisions which require the Company to make payments for exclusivity in the development of products in the area of loop diuretics. Contingencies The Company follows subtopic 450-20 of the FASB Accounting Standards Codification to report accounting for contingencies. Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed. Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Due to the discontinuation of use of the sc2Wear Infusor, the Company has received notice of termination costs related to the program. The Company has accrued all costs for which it either believes it is contractually liable or for which the Company has negotiated settlement agreements in good faith. However, certain of the Company’s vendors have claimed or billed for additional costs for which the Company believes it is not obligated. At this time, the Company estimates that additional termination costs, if any, will be immaterial to the Company’s financial statements.

Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reported periods. Actual results could differ from those estimates.

Cash, Cash Equivalents and Restricted Cash Cash, cash equivalents and restricted cash consists of bank deposits and money market accounts with financial institutions. Cash equivalents are carried at cost which approximates fair value due to their short-term nature and which the Company believes do not have a material exposure to credit risk. The Company considers all highly liquid investments with maturities of three months or less from the date of purchase to be cash equivalents. The Company’s cash and cash equivalent accounts, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts. As of March 31, 2021, the Company classified $182,000 as restricted cash related to a letter of credit issued as a security deposit in connection with the Company’s lease of its corporate office facilities (Note 11). Cash, cash equivalents and restricted cash consists of the following (in thousands):   <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.32%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.32%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">December 31, <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.32%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">March 31, <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.32%;"> Cash and cash equivalents</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.32%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">71,819</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.32%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75,837</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.32%; border-bottom:solid 0.75pt transparent;"> Restricted cash</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.32%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">182</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.32%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">182</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.32%; border-bottom:double 2.5pt transparent;"> Cash, cash equivalents and restricted cash</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.32%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72,001</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.32%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76,019</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> </tr> </table></div>

Concentration of Credit Risk Financial instruments that subject the Company to credit risk primarily consist of cash and cash equivalents and short-term investments. The Company maintains its cash and cash equivalent balances with high-quality financial institutions and, consequently, the Company believes that such funds are subject to minimal credit risk. The Company’s short-term investments consist of United States Treasury securities, corporate debt securities and commercial paper. The Company has adopted an investment policy that limits the amounts the Company may invest in any one type of investment and requires all investments held by the Company to hold a minimum rating, thereby reducing credit risk exposure.

Investments The Company invests excess cash balances in available-for-sale debt securities. The Company determines the appropriate classification of these securities at the time they are acquired and evaluates the appropriateness of such classifications at each balance sheet date. The Company reports available-for-sale investments at fair value at each balance sheet date and includes any unrealized gains and losses in accumulated other comprehensive income (loss), a component of stockholders’ equity. Realized gains and losses are determined using the specific identification method and are included in other income (expense). If any adjustment to fair value reflects a decline in the value of the investment, the Company considers all available evidence to evaluate the extent to which the decline is “other than temporary,” including the intention to sell and, if so, marks the investment to market through a charge to the Company’s consolidated statements of operations and comprehensive loss.

Leases The Company determines if an arrangement is a lease at inception. Operating leases are included in right-of-use (“ROU”) lease assets, current portion of lease obligations, and long-term lease obligations on the Company’s balance sheets.   ROU lease assets represent the Company’s right to use an underlying asset for the lease term and lease obligations represent the Company’s obligation to make lease payments arising from the lease. Operating ROU lease assets and obligations are recognized at the commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The ROU lease asset excludes lease incentives. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.

As of March 31, 2021, the Company classified $182,000 as restricted cash related to a letter of credit issued as a security deposit in connection with the Company’s lease of its corporate office facilities (Note 11). Cash, cash equivalents and restricted cash consists of the following (in thousands):   <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.32%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.32%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">December 31, <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.32%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">March 31, <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.32%;"> Cash and cash equivalents</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.32%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">71,819</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.32%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75,837</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.32%; border-bottom:solid 0.75pt transparent;"> Restricted cash</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.32%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">182</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.32%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">182</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.32%; border-bottom:double 2.5pt transparent;"> Cash, cash equivalents and restricted cash</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.32%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72,001</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.32%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76,019</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> </tr> </table></div>

The following table sets forth the computation of basic and diluted net loss per share of common stock (in thousands, except share and per share data):   <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended March 31,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;"> Net loss</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,092</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> )</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,102</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> )</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;"> Weighted-average shares used in computing net loss per share</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,218,473</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,336,724</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;"> Net loss per share, basic and diluted</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.35</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> )</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.26</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> )</td> </tr> </table></div>

The Company’s potentially dilutive securities, which include stock options and unvested restricted stock units, have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share. Therefore, the weighted average number of common shares outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same. The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect.   <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended March 31,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> Stock options to purchase common stock</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,058,355</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,805,029</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> Unvested restricted stock units</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">122,700</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,250</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;"> Total</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,181,055</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,847,279</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> </tr> </table></div>

A summary of the Company’s available-for-sale classified investments as of March 31, 2021 consisted of the following (in thousands): <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="14" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">At March 31, 2021</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;"> Investments - Current:</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Cost Basis</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Accumulated Unrealized Gains</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Accumulated Unrealized Losses</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> United States Treasury securities</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,705</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,706</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> Corporate debt securities</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,894</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> )</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,892</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;"> Commercial paper</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,892</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,892</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;"> Total</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,491</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> )</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,490</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> </tr> </table></div>

The amortized cost and fair value of the Company’s available-for-sale investments, by contract maturity, as of March 31, 2021 consisted of the following (in thousands): <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:90%;"> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Amortized Cost</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> Due in one year or less</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,491</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,490</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;"> Total</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,491</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,490</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> </tr> </table></div>

Purchased property and equipment consist of the following (dollars in thousands):   <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53.6%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.52%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.94%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">ESTIMATED <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">USEFUL LIFE</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.52%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.94%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">December 31, <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.52%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.94%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">March 31, <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53.6%;"> Office equipment</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.52%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.94%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5 years</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.52%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.52%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53.6%;"> Office furniture</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.52%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.94%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7 years</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.52%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">116</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.52%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">116</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53.6%;"> Computer equipment</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.52%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.94%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3 years</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.52%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.52%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53.6%; border-bottom:solid 0.75pt transparent;"> Leasehold improvements</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.52%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.94%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Life of lease</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.52%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">95</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.52%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">95</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53.6%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.52%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.94%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.52%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">229</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.52%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">229</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53.6%; border-bottom:solid 0.75pt transparent;"> Less: Accumulated depreciation</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.52%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.94%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.52%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(136</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> )</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.52%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(144</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> )</td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:53.6%; border-bottom:double 2.5pt transparent;"> Property and equipment, net</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.52%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.94%; border-bottom:double 2.5pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.52%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">93</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.52%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">85</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> </tr> </table></div>

Accrued expenses consist of the following (in thousands):   <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">December 31, <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">March 31, <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> Contract research and development</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,274</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,467</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> Employee compensation and related costs</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,978</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">689</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> Consulting and professional service fees</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">364</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">203</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> Interest</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">88</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">88</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> Financing related costs</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">86</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> State taxes</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">52</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total accrued expenses</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,787</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,585</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> </tr> </table></div>

The following tables summarize the Company’s assets that are measured at fair value on a recurring basis and indicates the level of the fair value hierarchy utilized to determine such fair values (in thousands):   <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.82%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="14" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.92%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.82%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.22%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">TOTAL</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Quoted Prices <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">in Active <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Markets <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">(Level 1)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-top:solid 0.75pt #000000;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Significant <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Other <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Observable <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Inputs <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">(Level 2)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-top:solid 0.75pt #000000;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Significant <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Unobservable <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Inputs <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">(Level 3)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.82%;"> Assets:</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.22%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash equivalents</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.22%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70,797</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">68,798</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,999</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.22%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70,797</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">68,798</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,999</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.22%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.82%;"> United States Treasury securities</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.22%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,213</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,213</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.82%;"> Corporate debt securities</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.22%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,973</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,973</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.82%; border-bottom:solid 0.75pt transparent;"> Commercial paper</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.22%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,090</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,090</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Investments</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.22%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33,276</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,213</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,063</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.22%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.82%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.22%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">104,073</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">77,011</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,062</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.22%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.22%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="14" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.92%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">As of March 31, 2021</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.82%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.22%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">TOTAL</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Quoted Prices <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">in Active <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Markets <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">(Level 1)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-top:solid 0.75pt #000000;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Significant <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Other <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Observable <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Inputs <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">(Level 2)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-top:solid 0.75pt #000000;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Significant <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Unobservable <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Inputs <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">(Level 3)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.82%;"> Assets:</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.22%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash equivalents</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.22%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75,115</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75,115</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.22%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75,115</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75,115</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.22%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.82%;"> United States Treasury securities</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.22%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,706</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,706</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.82%;"> Corporate debt securities</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.22%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,892</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,892</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.82%; border-bottom:solid 0.75pt transparent;"> Commercial paper</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.22%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,892</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,892</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Investments</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.22%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,490</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,706</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,784</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.22%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.82%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.22%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">95,605</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">78,821</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,784</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.22%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> </table></div>

Total term loan and unamortized debt discount balances are as follows (in thousands):   <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">March 31, <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;"> Face value</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,000</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;"> Less: discount</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(647</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> )</td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;"> Total</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,353</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;"> Less: current portion</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,838</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> )</td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,515</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> </tr> </table></div>

As of March 31, 2021, future principal payments due under the 2019 Loan Agreement are as follows (in thousands):   <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.9%;"> Year ended:</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.98%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2021</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.98%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,500</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2022</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.98%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,000</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.9%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2023</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.98%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,500</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.9%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.98%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,000</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> </tr> </table></div>

The fair value of options at date of grant was estimated using the Black-Scholes option-pricing model with the following assumptions:    <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">March 31,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> Risk-free interest rate</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td colspan="2" valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.93% - 1.71%</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td colspan="2" valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.50% - 0.72%</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> Expected dividend yield</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0%</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0%</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> Expected life</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td colspan="2" valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.5-6.6 years</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td colspan="2" valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.5-6.7 years</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> Expected volatility</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72%-73%</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72%-74%</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> Weighted-average grant date fair value</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.91</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.36</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> </table></div>

The following table summarizes information about stock option activity during the three months ended March 31, 2021 (in thousands, except share and per share data):    <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">NUMBER OF <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">SHARES</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">WEIGHTED- <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">AVERAGE <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">EXERCISE <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">PRICE</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">WEIGHTED- <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">AVERAGE <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">REMAINING <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">CONTRACTUAL <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">TERM</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">AGGREGATE <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">INTRINSIC <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">VALUE</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> Outstanding, December 31, 2020</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,224,913</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.26</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> Granted</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">785,406</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.84</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> Exercised</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,500</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> )</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.81</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;"> Forfeited</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(202,790</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> )</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.62</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;"> Outstanding, March 31, 2021</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,805,029</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.32</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.18</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,926</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> Vested and exercisable, March 31, 2021</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,125,780</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.66</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.64</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,222</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;"> Vested and expected to vest, March 31, 2021</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,013,825</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.26</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.76</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,541</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> </tr> </table></div>

The following table summarizes information about RSU activity during the three months ended March 31, 2021:   <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">RSUs</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">AVERAGE GRANT DATE FAIR VALUE (IN DOLLARS PER SHARE)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> Outstanding, December 31, 2020</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">80,450</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.25</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> Granted</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> Vested</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(38,200</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> )</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.25</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> Forfeited</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.88%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;"> RSUs outstanding at March 31, 2021</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,250</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.88%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.25</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> </tr> </table></div>

The Company recorded stock-based compensation expense in the following expense categories of its accompanying condensed consolidated statements of operations and comprehensive loss for the three months ended March 31, 2020 and 2021 (in thousands):   <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended March 31,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">  </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> Research and development</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">144</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">226</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> General and administrative</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">364</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">295</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;"> Total</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">508</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">521</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> </tr> </table></div>

The following is a maturity analysis of the annual undiscounted cash flows of the operating lease liabilities as of March 31, 2021 (in thousands):   <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;"> Year ended:</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;"> December 31, 2021</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">401</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;"> December 31, 2022</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">496</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;"> Total minimum lease payments</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">897</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;"> Less imputed interest</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(69</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> )</td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;"> Total</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">828</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> </tr> </table></div>

<div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:64.84%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.42%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">March 31,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:64.84%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2021</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64.84%;"> Lease cost:</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64.84%;"> Operating lease cost</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">122</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">122</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64.84%;"> Short-term lease cost</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:64.84%; border-bottom:solid 0.75pt transparent;"> Sublease income</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(12</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> )</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(13</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> )</td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:64.84%; border-bottom:double 2.5pt transparent;"> Total lease cost</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">110</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">109</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64.84%;"> Other information</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64.84%;"> Cash paid for amounts included in the measurement of lease liabilities</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">173</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">141</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64.84%;"> Operating cash flows from operating leases</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(10</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> )</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> $</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(14</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> )</td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64.84%;"> Weighted-average remaining lease term - operating leases</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">  </td> <td colspan="2" valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.7 years</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.7 years</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64.84%;"> Weighted-average discount rate - operating leases</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.1</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> %</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.1</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> %</td> </tr> </table></div>

96500000

182000

2058355

2805029

122700

42250

2181055

2847279

3705000

6894000

9892000

20491000

1000

2000

3706000

6892000

9892000

20490000

20491000

20490000

P5Y

P7Y

P3Y

Life of lease

10000

116000

8000

95000

229000

136000

144000

2274000 2467000

1978000

689000

364000

203000

88000

43000 86000

40000

52000

70797000

68798000

1999000

8213000

11973000

13090000

33276000

8213000

25063000

104073000

77011000

27062000

75115000

3706000

6892000

9892000

20490000

3706000

16784000

95605000

78821000

16784000

10000000

2021-05-01

20000000

2023-09-17

P4Y

325000

0.0795

The interest rate under the 2019 Loan Agreement is the higher of (i) LIBOR plus 7.95% or (ii) 10.18%

0.1018

0.04 800000 763000 30000

20000000

87000

81000

0.03 0.01 0.005 500000 40000 40000 0.05

20000000

647000

19353000

4838000

14515000

2500000

10000000

7500000

15000000 0.030

189000

1502892

7.13

10400000

135000

50000000 0.030

2017-11-30

2027-10-31

2017-11-30

600688

5051921

359651

2775526

P10Y

P1Y

P4Y

2204341

42250

0.0093

0.0050

0.0171

0.0072

0.00

P5Y6M

P6Y7M6D

P6Y8M12D

0.72

0.73

0.74

3.91

4.36

2224913

785406

2500

202790

2805029

1125780

2013825

6.26

6.84

3.81

7.62

6.32

5.66

6.26

P8Y2M4D

P6Y7M20D

P7Y9M3D

2926000

2222000

2541000

112050

80450

38200

42250

3.25

3600000

P2Y8M12D

41000

P1Y

144000

226000

364000

295000

508000

521000

2022

182000

401000

496000

897000

69000

828000

122000

12000

13000

110000

109000

173000 141000 -10000 -14000

P2Y8M12D

P1Y8M12D

0.101

P3Y

EX-101.SCH 5 scph-20210331.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000 - Document - Template Link link:presentationLink link:calculationLink link:definitionLink 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink 100010 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) link:calculationLink link:presentationLink link:definitionLink 100020 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 100030 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) link:calculationLink link:presentationLink link:definitionLink 100040 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) link:calculationLink link:presentationLink link:definitionLink 100050 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) link:calculationLink link:presentationLink link:definitionLink 100060 - Disclosure - Description of Business and Basis of Presentation link:calculationLink link:presentationLink link:definitionLink 100070 - Disclosure - Significant Accounting Policies link:calculationLink link:presentationLink link:definitionLink 100080 - Disclosure - Net Loss per Share link:calculationLink link:presentationLink link:definitionLink 100090 - Disclosure - Investments link:calculationLink link:presentationLink link:definitionLink 100100 - Disclosure - Property and Equipment link:calculationLink link:presentationLink link:definitionLink 100110 - Disclosure - Accrued Expenses link:calculationLink link:presentationLink link:definitionLink 100120 - Disclosure - Fair Value of Financial Instruments link:calculationLink link:presentationLink link:definitionLink 100130 - Disclosure - Term Loan link:calculationLink link:presentationLink link:definitionLink 100140 - Disclosure - Stockholders' Equity link:calculationLink link:presentationLink link:definitionLink 100150 - Disclosure - Stock-Based Compensation link:calculationLink link:presentationLink link:definitionLink 100160 - Disclosure - Commitments and Contingencies link:calculationLink link:presentationLink link:definitionLink 100170 - Disclosure - Significant Accounting Policies (Policies) link:calculationLink link:presentationLink link:definitionLink 100180 - Disclosure - Significant Accounting Policies (Tables) link:calculationLink link:presentationLink link:definitionLink 100190 - Disclosure - Net Loss per Share (Tables) link:calculationLink link:presentationLink link:definitionLink 100200 - Disclosure - Investments (Tables) link:calculationLink link:presentationLink link:definitionLink 100210 - Disclosure - Property and Equipment (Tables) link:calculationLink link:presentationLink link:definitionLink 100220 - Disclosure - Accrued Expenses (Tables) link:calculationLink link:presentationLink link:definitionLink 100230 - Disclosure - Fair Value of Financial Instruments (Tables) link:calculationLink link:presentationLink link:definitionLink 100240 - Disclosure - Term Loan (Tables) link:calculationLink link:presentationLink link:definitionLink 100250 - Disclosure - Stock-Based Compensation (Tables) link:calculationLink link:presentationLink link:definitionLink 100260 - Disclosure - Commitments and Contingencies (Tables) link:calculationLink link:presentationLink link:definitionLink 100270 - Disclosure - Description of Business and Basis of Presentation - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100280 - Disclosure - Significant Accounting Policies - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100290 - Disclosure - Significant Accounting Policies - Schedule of Cash, Cash Equivalents and Restricted Cash (Details) link:calculationLink link:presentationLink link:definitionLink 100300 - Disclosure - Net Loss per Share - Computation of Basic and Diluted Net Loss Per Share of Common Stock (Details) link:calculationLink link:presentationLink link:definitionLink 100310 - Disclosure - Net Loss per Share - Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share (Details) link:calculationLink link:presentationLink link:definitionLink 100320 - Disclosure - Investments - Summary of Available-for-Sale Classified Investments (Details) link:calculationLink link:presentationLink link:definitionLink 100330 - Disclosure - Investments - Summary of Amortized Cost and Fair Value of Available-for-Sale Investments by Contract Maturity (Details) link:calculationLink link:presentationLink link:definitionLink 100340 - Disclosure - Property and Equipment - Schedule of Purchased Property and Equipment (Details) link:calculationLink link:presentationLink link:definitionLink 100350 - Disclosure - Property and Equipment - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100360 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Details) link:calculationLink link:presentationLink link:definitionLink 100370 - Disclosure - Fair Value of Financial Instruments - Summary of Assets Measured at Fair Value on Recurring Basis (Details) link:calculationLink link:presentationLink link:definitionLink 100380 - Disclosure - Term Loan - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100390 - Disclosure - Term Loan - Schedule of Total Term Loan and Unamortized Debt Discount (Details) link:calculationLink link:presentationLink link:definitionLink 100400 - Disclosure - Term Loan - Schedule of Total Term Loan and Unamortized Debt Discount (Details)2 link:calculationLink link:presentationLink link:definitionLink 100410 - Disclosure - Term Loan - Schedule of Future Principal Payments Due (Details) link:calculationLink link:presentationLink link:definitionLink 100420 - Disclosure - Stockholders' Equity - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100430 - Disclosure - Stock-Based Compensation - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100440 - Disclosure - Stock-Based Compensation - Schedule of Estimated Fair Value of Options Valuation Assumptions (Details) link:calculationLink link:presentationLink link:definitionLink 100450 - Disclosure - Stock-Based Compensation - Summary of Information about Stock Option Activity (Details) link:calculationLink link:presentationLink link:definitionLink 100460 - Disclosure - Stock-Based Compensation - Schedule of RSU Activity (Details) link:calculationLink link:presentationLink link:definitionLink 100470 - Disclosure - Stock-Based Compensation - Summary of Stock Based Compensation Expense (Details) link:calculationLink link:presentationLink link:definitionLink 100480 - Disclosure - Commitments and Contingencies - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100490 - Disclosure - Commitments and Contingencies - Schedule of Maturity Analysis of Annual Undiscounted Cash Flows of Operating Lease Liabilities (Details) link:calculationLink link:presentationLink link:definitionLink 100500 - Disclosure - Commitments and Contingencies - Schedule of Maturity Analysis of Annual Undiscounted Cash Flows of Operating Lease Liabilities (Details)2 link:calculationLink link:presentationLink link:definitionLink 100510 - Disclosure - Commitments and Contingencies - Schedule of Lease Cost and Other Information of Operating Lease Liabilities (Details) link:calculationLink link:presentationLink link:definitionLink EX-101.CAL 6 scph-20210331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 7 scph-20210331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 8 scph-20210331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity Central Index Key Cover [Abstract] Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Trading Symbol Trading Symbol Entity Registrant Name Entity Registrant Name Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Entity Current Reporting Status Entity Current Reporting Status Entity Small Business Entity Small Business Entity Emerging Growth Company Entity Emerging Growth Company Entity Ex Transition Period Entity Ex Transition Period Entity Shell Company Entity Shell Company Entity Interactive Data Current Entity Interactive Data Current Title of 12(b) Security Security12b Title Security Exchange Name Security Exchange Name Entity File Number Entity File Number Entity Incorporation, State or Country Code Entity Incorporation State Country Code Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address Address Line1 Entity Address, Address Line Two Entity Address Address Line2 Entity Address, City or Town Entity Address City Or Town Entity Address, State or Province Entity Address State Or Province Entity Address, Postal Zip Code Entity Address Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Document Quarterly Report Document Quarterly Report Document Transition Report Document Transition Report Entity Common Stock, Shares Outstanding Entity Common Stock Shares Outstanding Deposits and other assets noncurrent . Statement Of Financial Position [Abstract] Assets Assets [Abstract] Current assets Assets Current [Abstract] Cash and cash equivalents Cash And Cash Equivalents At Carrying Value Short-term investments Short Term Investments Prepaid expenses Prepaid Expense Current Other current assets Other Assets Current Total current assets Assets Current Restricted cash Restricted Cash Noncurrent Property and equipment, net Property Plant And Equipment Net Right-of-use lease assets - operating, net Operating Lease Right Of Use Asset Deposits and other assets Deposits And Other Assets Noncurrent Total assets Assets Liabilities and Stockholders’ Equity Liabilities And Stockholders Equity [Abstract] Current liabilities Liabilities Current [Abstract] Accounts payable Accounts Payable Current Accrued expenses Accrued Liabilities Current Term loan, short-term Long Term Debt Current Lease obligation - operating, short-term Operating Lease Liability Current Total current liabilities Liabilities Current Term loan, long-term Long Term Debt Noncurrent Lease obligation - operating, long-term Operating Lease Liability Noncurrent Other liabilities Other Liabilities Noncurrent Total liabilities Liabilities Commitments and contingencies (Note 11) Commitments And Contingencies Stockholders’ equity Stockholders Equity [Abstract] Preferred stock, $0.0001 par value; 10,000,000 shares authorized and no shares issued and outstanding Preferred Stock Value Common stock, $0.0001 par value; 150,000,000 shares authorized as of March 31, 2021; 27,325,959 and 27,355,453 shares issued and outstanding as of December 31, 2020 and March 31, 2021, respectively Common Stock Value Additional paid-in capital Additional Paid In Capital Common Stock Accumulated deficit Retained Earnings Accumulated Deficit Accumulated other comprehensive gain (loss) Accumulated Other Comprehensive Income Loss Net Of Tax Total stockholders’ equity Stockholders Equity Total liabilities and stockholders’ equity Liabilities And Stockholders Equity Preferred stock, par value Preferred Stock Par Or Stated Value Per Share Preferred stock, shares authorized Preferred Stock Shares Authorized Preferred stock, shares issued Preferred Stock Shares Issued Preferred stock, shares outstanding Preferred Stock Shares Outstanding Common stock, par value Common Stock Par Or Stated Value Per Share Common stock, shares authorized Common Stock Shares Authorized Common stock, shares issued Common Stock Shares Issued Common stock, shares outstanding Common Stock Shares Outstanding Income Statement [Abstract] Operating expenses: Operating Expenses [Abstract] Research and development Research And Development Expense General and administrative General And Administrative Expense Total operating expenses Operating Expenses Loss from operations Operating Income Loss Other (expense) income Other Nonoperating Income Expense Interest income Investment Income Interest Interest expense Interest Expense Net loss Net Income Loss Net loss per share — basic and diluted Earnings Per Share Basic And Diluted Weighted average common shares outstanding — basic and diluted Weighted Average Number Of Share Outstanding Basic And Diluted Other comprehensive loss: Other Comprehensive Income Loss Net Of Tax Period Increase Decrease [Abstract] Unrealized loss on short-term investments Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax Comprehensive loss Comprehensive Income Net Of Tax Statement Of Stockholders Equity [Abstract] Statement [Table] Statement [Table] Equity Components Statement Equity Components [Axis] Equity Component Equity Component [Domain] Common Stock Common Stock [Member] Additional Paid-in Capital Additional Paid In Capital [Member] Accumulated Deficit Retained Earnings [Member] Other Comprehensive Income Accumulated Other Comprehensive Income [Member] Sale of Stock Subsidiary Sale Of Stock [Axis] Sale of Stock Sale Of Stock Name Of Transaction [Domain] At the market offering. At The Market Offering At The Market Offering [Member] Statement [Line Items] Statement [Line Items] Beginning Balance Beginning Balance, Shares Shares Outstanding Net loss Profit Loss Issuance of common stock, net of commissions and issuance costs Stock Issued During Period Value New Issues Issuance of common stock net of commissions and issuance costs, Shares Stock Issued During Period Shares New Issues Issuance of common stock upon exercise of stock options Stock Issued During Period Value Stock Options Exercised Issuance of common stock upon exercise of stock options, Shares Stock Issued During Period Shares Stock Options Exercised Vesting of restricted stock Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures Vesting of restricted stock, Shares Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures Stock-based compensation Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value Ending Balance Ending Balance, Shares Fair value adjustment to derivative liability. Taxes paid. Transfer of issuance costs from other noncurrent assets to equity. Statement Of Cash Flows [Abstract] Cash flows from operating activities Net Cash Provided By Used In Operating Activities [Abstract] Adjustments to reconcile net loss to cash used in operating activities Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract] Depreciation expense Depreciation Amortization expense - right-of-use leased assets - operating Amortization Of Leased Asset Accretion expense Accretion Expense Stock-based compensation Share Based Compensation Non-cash interest expense Paid In Kind Interest Fair value adjustment to derivative liability Fair Value Adjustment To Derivative Liability Changes in operating assets and liabilities Increase Decrease In Operating Capital [Abstract] Prepaid expenses and other assets Increase Decrease In Prepaid Deferred Expense And Other Assets Accounts payable, accrued expenses and other liabilities Increase Decrease In Accounts Payable And Accrued Liabilities Net cash used in operating activities Net Cash Provided By Used In Operating Activities Cash flows from investing activities Net Cash Provided By Used In Investing Activities [Abstract] Maturities of short-term investments Proceeds From Maturities Prepayments And Calls Of Shortterm Investments Purchases of short-term investments Payments To Acquire Short Term Investments Net cash provided by investing activities Net Cash Provided By Used In Investing Activities Cash flows from financing activities Net Cash Provided By Used In Financing Activities [Abstract] Proceeds from at-the-market offering, net Proceeds From Issuance Of Common Stock Proceeds from the exercise of vested stock options Proceeds From Stock Options Exercised Settlements of restricted stock units for tax withholding obligations Payments Related To Tax Withholding For Share Based Compensation Net cash provided by (used in) financing activities Net Cash Provided By Used In Financing Activities Net increase in cash, cash equivalents and restricted cash Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Cash, cash equivalents and restricted cash at beginning of period Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Cash, cash equivalents and restricted cash at end of period Supplemental cash flow information Supplemental Cash Flow Information [Abstract] Interest paid Interest Paid Net Taxes paid Taxes Paid Supplemental non-cash information Additional Cash Flow Elements And Supplemental Cash Flow Information [Abstract] Transfer of issuance costs from other noncurrent assets to equity Transfer Of Issuance Costs From Other Noncurrent Assets To Equity Organization Consolidation And Presentation Of Financial Statements [Abstract] Description of Business and Basis of Presentation Business Description And Basis Of Presentation [Text Block] Accounting Policies [Abstract] Significant Accounting Policies Significant Accounting Policies [Text Block] Earnings Per Share [Abstract] Net Loss per Share Earnings Per Share [Text Block] Investments Debt And Equity Securities [Abstract] Investments Investments In Debt And Marketable Equity Securities And Certain Trading Assets Disclosure [Text Block] Property Plant And Equipment [Abstract] Property and Equipment Property Plant And Equipment Disclosure [Text Block] Accrued liabilities. Accrued Liabilities Current [Abstract] Accrued Expenses Accrued Liabilities Disclosure [Text Block] Fair Value Disclosures [Abstract] Fair Value of Financial Instruments Fair Value Disclosures [Text Block] Debt Disclosure [Abstract] Term Loan Debt Disclosure [Text Block] Equity [Abstract] Stockholders' Equity Stockholders Equity Note Disclosure [Text Block] Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] Stock-Based Compensation Disclosure Of Compensation Related Costs Share Based Payments [Text Block] Commitments And Contingencies Disclosure [Abstract] Commitments and Contingencies Commitments And Contingencies Disclosure [Text Block] Use of Estimates Use Of Estimates Cash Cash Equivalents and Restricted Cash Cash And Cash Equivalents Restricted Cash And Cash Equivalents Policy Concentration of Credit Risk Concentration Risk Credit Risk Investments Investment Policy [Text Block] Leases Lessee Leases Policy [Text Block] Income Taxes Income Tax Policy [Text Block] Schedule of cash cash equivalents and restricted cash. Schedule of Cash, Cash Equivalents and Restricted Cash Schedule Of Cash Cash Equivalents And Restricted Cash Table [Text Block] Computation of Basic and Diluted Net Loss Per Share of Common Stock Schedule Of Earnings Per Share Basic And Diluted Table [Text Block] Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block] Summary of Available-for-Sale Classified Investments Unrealized Gain Loss On Investments Table [Text Block] Summary of Amortized Cost and Fair Value of Available-for-Sale Investments by Contract Maturity Investments Classified By Contractual Maturity Date Table [Text Block] Schedule of Purchased Property and Equipment Property Plant And Equipment [Text Block] Schedule of Accrued Expenses Schedule Of Accrued Liabilities Table [Text Block] Summary of Assets Measured at Fair Value on Recurring Basis Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Table [Text Block] Schedule of Total Term Loan and Unamortized Debt Discount Schedule Of Debt Table [Text Block] Schedule of Future Principal Payments Due Schedule Of Maturities Of Long Term Debt Table [Text Block] Schedule of Estimated Fair Value of Options Valuation Assumptions Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block] Summary of Information about Stock Option Activity Schedule Of Share Based Compensation Stock Options Activity Table [Text Block] Schedule of RSU Activity Schedule Of Nonvested Restricted Stock Units Activity Table [Text Block] Summary of Stock-Based Compensation Expense Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block] Schedule of Maturity Analysis of Annual Undiscounted Cash Flows of Operating Lease Liabilities Lessee Operating Lease Liability Maturity Table [Text Block] Schedule of Lease Cost and Other Information of Operating Lease Liabilities Lease Cost Table [Text Block] Cash, cash equivalents, restricted cash, and short-term investments. Cash, cash equivalents, restricted cash, and short-term investments Cash Cash Equivalents Restricted Cash And Short Term Investments Schedule of accounting policies. Schedule of accounting policies. Schedule Of Accounting Policies [Table] Schedule Of Accounting Policies [Table] Credit Facility Credit Facility [Axis] Credit Facility Credit Facility [Domain] Letter of Credit Letter Of Credit [Member] Schedule Of Accounting Policies [Line Items] Schedule Of Accounting Policies [Line Items] Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents [Abstract] Cash and cash equivalents Cash, cash equivalents and restricted cash Potential interest and penalties associated with uncertain tax positions, accruals Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued Net loss Weighted-average shares used in computing net loss per share Net loss per share, basic and diluted Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] EX-101.PRE 9 scph-20210331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 10 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	3 Months Ended
Document and Entity Information - shares	Mar. 31, 2021	May 12, 2021
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2021
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q1
Trading Symbol	SCPH
Entity Registrant Name	SCPHARMACEUTICALS INC.
Entity Central Index Key	0001604950
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Current Reporting Status	Yes
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	true
Entity Shell Company	false
Entity Interactive Data Current	Yes
Title of 12(b) Security	Common stock, par value $0.0001
Security Exchange Name	NASDAQ
Entity File Number	001-38293
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	46-5184075
Entity Address, Address Line One	2400 District Avenue
Entity Address, Address Line Two	Suite 310
Entity Address, City or Town	Burlington
Entity Address, State or Province	MA
Entity Address, Postal Zip Code	01803
City Area Code	617
Local Phone Number	517-0730
Document Quarterly Report	true
Document Transition Report	false
Entity Common Stock, Shares Outstanding		27,355,454

XML 11 R2.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Current assets
Cash and cash equivalents	$ 75,837	$ 71,819
Short-term investments	20,490	33,276
Prepaid expenses	2,637	2,610
Other current assets	102	121
Total current assets	99,066	107,826
Restricted cash	182	182
Property and equipment, net	85	93
Right-of-use lease assets - operating, net	717	815
Deposits and other assets	243	132
Total assets	100,293	109,048
Current liabilities
Accounts payable	753	1,666
Accrued expenses	3,585	4,787
Term loan, short-term	4,838	2,408
Lease obligation - operating, short-term	472	460
Total current liabilities	9,648	9,321
Term loan, long-term	14,515	16,858
Lease obligation - operating, long-term	356	480
Other liabilities	259	219
Total liabilities	24,778	26,878
Commitments and contingencies (Note 11)
Stockholders’ equity
Preferred stock, $0.0001 par value; 10,000,000 shares authorized and no shares issued and outstanding
Common stock, $0.0001 par value; 150,000,000 shares authorized as of March 31, 2021; 27,325,959 and 27,355,453 shares issued and outstanding as of December 31, 2020 and March 31, 2021, respectively	3	3
Additional paid-in capital	244,279	243,830
Accumulated deficit	(168,766)	(161,664)
Accumulated other comprehensive gain (loss)	(1)	1
Total stockholders’ equity	75,515	82,170
Total liabilities and stockholders’ equity	$ 100,293	$ 109,048

XML 12 R3.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares	Mar. 31, 2021	Dec. 31, 2020
Statement Of Financial Position [Abstract]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.0001
Common stock, shares authorized	150,000,000
Common stock, shares issued	27,355,453	27,325,959
Common stock, shares outstanding	27,355,453	27,325,959

XML 13 R4.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Operating expenses:
Research and development	$ 4,009	$ 4,146
General and administrative	2,732	2,503
Total operating expenses	6,741	6,649
Loss from operations	(6,741)	(6,649)
Other (expense) income	255	(31)
Interest income	20	224
Interest expense	(636)	(636)
Net loss	$ (7,102)	$ (7,092)
Net loss per share — basic and diluted	$ (0.26)	$ (0.35)
Weighted average common shares outstanding — basic and diluted	27,336,724	20,218,473
Other comprehensive loss:
Unrealized loss on short-term investments	$ (2)
Comprehensive loss	$ (7,104)	$ (7,092)

XML 14 R5.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands	Total	At The Market Offering	Common Stock	Common Stock At The Market Offering	Additional Paid-in Capital	Additional Paid-in Capital At The Market Offering	Accumulated Deficit	Other Comprehensive Income
Beginning Balance at Dec. 31, 2019	$ 51,365		$ 2		$ 180,818		$ (129,455)
Beginning Balance, Shares at Dec. 31, 2019			19,418,955
Net loss	(7,092)						(7,092)
Issuance of common stock, net of commissions and issuance costs		$ 10,253				$ 10,253
Issuance of common stock net of commissions and issuance costs, Shares				1,502,892
Issuance of common stock upon exercise of stock options	154				154
Issuance of common stock upon exercise of stock options, Shares			30,143
Vesting of restricted stock	(84)				(84)
Vesting of restricted stock, Shares			29,890
Stock-based compensation	508				508
Ending Balance at Mar. 31, 2020	55,104		$ 2		191,649		(136,547)
Ending Balance, Shares at Mar. 31, 2020			20,981,880
Beginning Balance at Dec. 31, 2020	82,170		$ 3		243,830		(161,664)	$ 1
Beginning Balance, Shares at Dec. 31, 2020			27,325,959
Net loss	(7,102)						(7,102)
Issuance of common stock upon exercise of stock options	$ 9				9
Issuance of common stock upon exercise of stock options, Shares	2,500		2,500
Vesting of restricted stock	$ (81)				(81)
Vesting of restricted stock, Shares			26,994
Stock-based compensation	521				521
Unrealized loss on short-term investments	(2)							(2)
Ending Balance at Mar. 31, 2021	$ 75,515		$ 3		$ 244,279		$ (168,766)	$ (1)
Ending Balance, Shares at Mar. 31, 2021			27,355,453

XML 15 R6.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cash flows from operating activities
Net loss	$ (7,102,000)	$ (7,092,000)
Adjustments to reconcile net loss to cash used in operating activities
Depreciation expense	8,000	8,000
Amortization expense - right-of-use leased assets - operating	98,000	87,000
Accretion expense	79,000
Stock-based compensation	521,000	508,000
Non-cash interest expense	127,000	121,000
Fair value adjustment to derivative liability		30,000
Changes in operating assets and liabilities
Prepaid expenses and other assets	(119,000)	(720,000)
Accounts payable, accrued expenses and other liabilities	(2,227,000)	(685,000)
Net cash used in operating activities	(8,615,000)	(7,743,000)
Cash flows from investing activities
Maturities of short-term investments	16,700,000
Purchases of short-term investments	(3,995,000)
Net cash provided by investing activities	12,705,000
Cash flows from financing activities
Proceeds from at-the-market offering, net		10,388,000
Proceeds from the exercise of vested stock options	9,000	154,000
Settlements of restricted stock units for tax withholding obligations	(81,000)	(84,000)
Net cash provided by (used in) financing activities	(72,000)	10,458,000
Net increase in cash, cash equivalents and restricted cash	4,018,000	2,715,000
Cash, cash equivalents and restricted cash at beginning of period	72,001,000	72,806,000
Cash, cash equivalents and restricted cash at end of period	76,019,000	75,521,000
Supplemental cash flow information
Interest paid	597,000	518,000
Taxes paid	$ 42,000
Supplemental non-cash information
Transfer of issuance costs from other noncurrent assets to equity		$ 135,000

XML 16 R7.htm IDEA: XBRL DOCUMENT

Description of Business and Basis of Presentation

3 Months Ended

Mar. 31, 2021

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Description of Business and Basis of Presentation

1. Description of Business and Basis of Presentation

Description of Business

Basis of Presentation

Liquidity

XML 17 R8.htm IDEA: XBRL DOCUMENT

Significant Accounting Policies

3 Months Ended

Mar. 31, 2021

Accounting Policies [Abstract]

Significant Accounting Policies

2. Significant Accounting Policies

Use of Estimates

Cash, Cash Equivalents and Restricted Cash

Cash, cash equivalents and restricted cash consists of bank deposits and money market accounts with financial institutions. Cash equivalents are carried at cost which approximates fair value due to their short-term nature and which the Company believes do not have a material exposure to credit risk. The Company considers all highly liquid investments with maturities of three months or less from the date of purchase to be cash equivalents. The Company’s cash and cash equivalent accounts, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts.

	December 31, 2020		March 31, 2021
Cash and cash equivalents	$	71,819	$	75,837
Restricted cash		182		182
Cash, cash equivalents and restricted cash	$	72,001	$	76,019

Concentration of Credit Risk

Investments

Leases

Income Taxes

XML 18 R9.htm IDEA: XBRL DOCUMENT

Net Loss per Share

3 Months Ended

Mar. 31, 2021

Earnings Per Share [Abstract]

Net Loss per Share

3. Net Loss per Share

Net Loss per Share Attributable to Common Stockholders

The following table sets forth the computation of basic and diluted net loss per share of common stock (in thousands, except share and per share data):

	Three Months Ended March 31,
	2020			2021
Net loss	$	(7,092	)	$	(7,102	)
Weighted-average shares used in computing net loss per share		20,218,473			27,336,724
Net loss per share, basic and diluted	$	(0.35	)	$	(0.26	)

	Three Months Ended March 31,
	2020		2021
Stock options to purchase common stock		2,058,355		2,805,029
Unvested restricted stock units		122,700		42,250
Total		2,181,055		2,847,279

XML 19 R10.htm IDEA: XBRL DOCUMENT

Investments

3 Months Ended

Mar. 31, 2021

Investments Debt And Equity Securities [Abstract]

Investments

4. Investments

Cash in excess of the Company’s immediate requirements is invested in accordance with the Company’s investment policy that primarily seeks to maintain adequate liquidity and preserve capital.

A summary of the Company’s available-for-sale classified investments as of March 31, 2021 consisted of the following (in thousands):

	At March 31, 2021
Investments - Current:	Cost Basis		Accumulated Unrealized Gains		Accumulated Unrealized Losses			Fair Value
United States Treasury securities	$	3,705	$	1	$	-		$	3,706
Corporate debt securities		6,894		-		(2	)		6,892
Commercial paper		9,892		-		-			9,892
Total	$	20,491	$	1	$	(2	)	$	20,490

The amortized cost and fair value of the Company’s available-for-sale investments, by contract maturity, as of March 31, 2021 consisted of the following (in thousands):

	Amortized Cost		Fair Value
Due in one year or less	$	20,491	$	20,490
Total	$	20,491	$	20,490

XML 20 R11.htm IDEA: XBRL DOCUMENT

Property and Equipment

3 Months Ended

Mar. 31, 2021

Property Plant And Equipment [Abstract]

Property and Equipment

5. Property and Equipment

Purchased property and equipment consist of the following (dollars in thousands):

	ESTIMATED USEFUL LIFE	December 31, 2020			March 31, 2021
Office equipment	5 years	$	10		$	10
Office furniture	7 years		116			116
Computer equipment	3 years		8			8
Leasehold improvements	Life of lease		95			95
			229			229
Less: Accumulated depreciation			(136	)		(144	)
Property and equipment, net		$	93		$	85

Depreciation expense for the three months ended March 31, 2020 and March 31, 2021 was $8,000 and $8,000, respectively.

XML 21 R12.htm IDEA: XBRL DOCUMENT

Accrued Expenses

3 Months Ended

Mar. 31, 2021

Accrued Liabilities Current [Abstract]

Accrued Expenses

6. Accrued Expenses

Accrued expenses consist of the following (in thousands):

	December 31, 2020		March 31, 2021
Contract research and development	$	2,274	$	2,467
Employee compensation and related costs		1,978		689
Consulting and professional service fees		364		203
Interest		88		88
Financing related costs		43		86
State taxes		40		52
Total accrued expenses	$	4,787	$	3,585

XML 22 R13.htm IDEA: XBRL DOCUMENT

Fair Value of Financial Instruments

3 Months Ended

Mar. 31, 2021

Fair Value Disclosures [Abstract]

Fair Value of Financial Instruments

7. Fair Value of Financial Instruments

Level 1—Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.

Level 2—Valuations based on quoted prices for similar assets or liabilities in markets that are not active or for which all significant inputs are observable, either directly or indirectly.

Level 3—Valuations that require inputs that reflect the Company’s own assumptions that are both significant to the fair value measurement and observable.

	As of December 31, 2020
	TOTAL		Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets:
Cash equivalents	$	70,797	$	68,798	$	1,999	$	—
Total cash equivalents		70,797		68,798		1,999		—

United States Treasury securities		8,213		8,213		—		—
Corporate debt securities		11,973		—		11,973		—
Commercial paper		13,090		—		13,090		—
Investments		33,276		8,213		25,063		—

Total	$	104,073	$	77,011	$	27,062	$	—


	As of March 31, 2021
	TOTAL		Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets:
Cash equivalents	$	75,115	$	75,115	$	—	$	—
Total cash equivalents		75,115		75,115		—		—

United States Treasury securities		3,706		3,706		—		—
Corporate debt securities		6,892		—		6,892		—
Commercial paper		9,892		—		9,892		—
Investments		20,490		3,706		16,784		—

Total	$	95,605	$	78,821	$	16,784	$	—

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

XML 23 R14.htm IDEA: XBRL DOCUMENT

Term Loan

3 Months Ended

Mar. 31, 2021

Debt Disclosure [Abstract]

Term Loan

8. Term Loan

The Company entered into an Exit Agreement in connection with the 2019 Loan Agreement which provides for an aggregate payment of 4% of the loan commitment, or $800,000, to the lenders upon the occurrence of an exit event (the “Exit Fee). The Company concluded that the exit payment obligation met the definition of a derivative that was required to be accounted for as a separate unit of accounting. The Company recorded the issuance-date fair value of the derivative liability of $763,000 as a debt discount and as a derivative liability in the Company’s balance sheet. The derivative liability is re-measured at each balance sheet date and any changes in estimated fair value is recorded as other income (expense). The Company paid the Exit Fee during 2020 in conjunction with the Company’s public offering, which was deemed to be an exit event pursuant to the Exit Agreement. For the three months ended March 31, 2020, the Company recorded $30,000 in non-cash expense as a fair value adjustment to the derivative liability.

In an event of default under the 2019 Loan Agreement, the interest rate will be increased by 5% and the balance under the loan may become immediately due and payable at the option of the lenders.

Total term loan and unamortized debt discount balances are as follows (in thousands):

	March 31, 2021
Face value	$	20,000
Less: discount		(647	)
Total	$	19,353
Less: current portion		(4,838	)
Total	$	14,515

As of March 31, 2021, future principal payments due under the 2019 Loan Agreement are as follows (in thousands):

Year ended:
December 31, 2021	$	2,500
December 31, 2022		10,000
December 31, 2023		7,500
Total	$	20,000

XML 24 R15.htm IDEA: XBRL DOCUMENT

Stockholders' Equity

3 Months Ended

Mar. 31, 2021

Equity [Abstract]

Stockholders' Equity

9. Stockholders’ Equity

2019 At-the-Market Issuance Sales Agreement

During the three months ended March 31, 2020, the Company sold a total of 1,502,892 2019 ATM Shares under the 2019 ATM Agreement, in the open market, at a weighted average gross selling price of $7.13 per share for net proceeds of $10.4 million, which completed the program. The Company charged $135,000 in costs related to establishing and activating the program against additional paid in capital upon issuance of shares during the three months ended March 31, 2020.

2021 At-the-Market Issuance Sales Agreement

XML 25 R16.htm IDEA: XBRL DOCUMENT

Stock-Based Compensation

3 Months Ended

Mar. 31, 2021

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Stock-Based Compensation

10. Stock-Based Compensation

Stock Options

The fair value of options at date of grant was estimated using the Black-Scholes option-pricing model with the following assumptions:

	Three Months Ended March 31,
	2020		2021
Risk-free interest rate	0.93% - 1.71%		0.50% - 0.72%
Expected dividend yield	0%		0%
Expected life	5.5-6.6 years		5.5-6.7 years
Expected volatility	72%-73%		72%-74%
Weighted-average grant date fair value	$	3.91	$	4.36

The following table summarizes information about stock option activity during the three months ended March 31, 2021 (in thousands, except share and per share data):

	NUMBER OF SHARES			WEIGHTED- AVERAGE EXERCISE PRICE		WEIGHTED- AVERAGE REMAINING CONTRACTUAL TERM		AGGREGATE INTRINSIC VALUE
Outstanding, December 31, 2020		2,224,913		$	6.26
Granted		785,406			6.84
Exercised		(2,500	)		3.81
Forfeited		(202,790	)		7.62
Outstanding, March 31, 2021		2,805,029		$	6.32		8.18	$	2,926
Vested and exercisable, March 31, 2021		1,125,780		$	5.66		6.64	$	2,222
Vested and expected to vest, March 31, 2021		2,013,825		$	6.26		7.76	$	2,541

The following table summarizes information about RSU activity during the three months ended March 31, 2021:

	RSUs			AVERAGE GRANT DATE FAIR VALUE (IN DOLLARS PER SHARE)
Outstanding, December 31, 2020		80,450		$	3.25
Granted		—			—
Vested		(38,200	)		3.25
Forfeited		—			—
RSUs outstanding at March 31, 2021		42,250		$	3.25

The number of RSUs vested includes shares of common stock withheld on behalf of employees to satisfy the minimum statutory tax withholding requirements.

	Three Months Ended March 31,
	2020		2021
Research and development	$	144	$	226
General and administrative		364		295
Total	$	508	$	521

XML 26 R17.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies

3 Months Ended

Mar. 31, 2021

Commitments And Contingencies Disclosure [Abstract]

Commitments and Contingencies

11. Commitments and Contingencies

Operating Leases

The Company leases office facilities and equipment under long-term, non-cancelable operating lease agreements. The leases expire at various dates through 2022 and do not include renewal options.

The following is a maturity analysis of the annual undiscounted cash flows of the operating lease liabilities as of March 31, 2021 (in thousands):

Year ended:
December 31, 2021	$	401
December 31, 2022		496
Total minimum lease payments		897
Less imputed interest		(69	)
Total	$	828

	Three Months Ended March 31,
	2020			2021
Lease cost:
Operating lease cost	$	122		$	122
Short-term lease cost		-			-
Sublease income		(12	)		(13	)
Total lease cost	$	110		$	109
Other information
Cash paid for amounts included in the measurement of lease liabilities	$	173		$	141
Operating cash flows from operating leases	$	(10	)	$	(14	)
Weighted-average remaining lease term - operating leases	2.7 years			1.7 years
Weighted-average discount rate - operating leases		10.1	%		10.1	%

Research and Development Agreements

Contingencies

The Company follows subtopic 450-20 of the FASB Accounting Standards Codification to report accounting for contingencies.

XML 27 R18.htm IDEA: XBRL DOCUMENT

Significant Accounting Policies (Policies)

3 Months Ended

Mar. 31, 2021

Accounting Policies [Abstract]

Use of Estimates

Cash Cash Equivalents and Restricted Cash

Cash, Cash Equivalents and Restricted Cash

	December 31, 2020		March 31, 2021
Cash and cash equivalents	$	71,819	$	75,837
Restricted cash		182		182
Cash, cash equivalents and restricted cash	$	72,001	$	76,019

Concentration of Credit Risk

Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 954
-SubTopic 740
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 17
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319

+ Details

XML 28 R19.htm IDEA: XBRL DOCUMENT

Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2021

Accounting Policies [Abstract]

Schedule of Cash, Cash Equivalents and Restricted Cash

	December 31, 2020		March 31, 2021
Cash and cash equivalents	$	71,819	$	75,837
Restricted cash		182		182
Cash, cash equivalents and restricted cash	$	72,001	$	76,019

XML 29 R20.htm IDEA: XBRL DOCUMENT

Net Loss per Share (Tables)

3 Months Ended

Mar. 31, 2021

Earnings Per Share [Abstract]

Computation of Basic and Diluted Net Loss Per Share of Common Stock

The following table sets forth the computation of basic and diluted net loss per share of common stock (in thousands, except share and per share data):

	Three Months Ended March 31,
	2020			2021
Net loss	$	(7,092	)	$	(7,102	)
Weighted-average shares used in computing net loss per share		20,218,473			27,336,724
Net loss per share, basic and diluted	$	(0.35	)	$	(0.26	)

Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share

	Three Months Ended March 31,
	2020		2021
Stock options to purchase common stock		2,058,355		2,805,029
Unvested restricted stock units		122,700		42,250
Total		2,181,055		2,847,279

XML 30 R21.htm IDEA: XBRL DOCUMENT

Investments (Tables)

3 Months Ended

Mar. 31, 2021

Investments Debt And Equity Securities [Abstract]

Summary of Available-for-Sale Classified Investments

A summary of the Company’s available-for-sale classified investments as of March 31, 2021 consisted of the following (in thousands):

	At March 31, 2021
Investments - Current:	Cost Basis		Accumulated Unrealized Gains		Accumulated Unrealized Losses			Fair Value
United States Treasury securities	$	3,705	$	1	$	-		$	3,706
Corporate debt securities		6,894		-		(2	)		6,892
Commercial paper		9,892		-		-			9,892
Total	$	20,491	$	1	$	(2	)	$	20,490

Summary of Amortized Cost and Fair Value of Available-for-Sale Investments by Contract Maturity

The amortized cost and fair value of the Company’s available-for-sale investments, by contract maturity, as of March 31, 2021 consisted of the following (in thousands):

	Amortized Cost		Fair Value
Due in one year or less	$	20,491	$	20,490
Total	$	20,491	$	20,490

XML 31 R22.htm IDEA: XBRL DOCUMENT

Property and Equipment (Tables)

3 Months Ended

Mar. 31, 2021

Property Plant And Equipment [Abstract]

Schedule of Purchased Property and Equipment

Purchased property and equipment consist of the following (dollars in thousands):

	ESTIMATED USEFUL LIFE	December 31, 2020			March 31, 2021
Office equipment	5 years	$	10		$	10
Office furniture	7 years		116			116
Computer equipment	3 years		8			8
Leasehold improvements	Life of lease		95			95
			229			229
Less: Accumulated depreciation			(136	)		(144	)
Property and equipment, net		$	93		$	85

XML 32 R23.htm IDEA: XBRL DOCUMENT

Accrued Expenses (Tables)

3 Months Ended

Mar. 31, 2021

Accrued Liabilities Current [Abstract]

Schedule of Accrued Expenses

Accrued expenses consist of the following (in thousands):

	December 31, 2020		March 31, 2021
Contract research and development	$	2,274	$	2,467
Employee compensation and related costs		1,978		689
Consulting and professional service fees		364		203
Interest		88		88
Financing related costs		43		86
State taxes		40		52
Total accrued expenses	$	4,787	$	3,585

XML 33 R24.htm IDEA: XBRL DOCUMENT

Fair Value of Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2021

Fair Value Disclosures [Abstract]

Summary of Assets Measured at Fair Value on Recurring Basis

	As of December 31, 2020
	TOTAL		Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets:
Cash equivalents	$	70,797	$	68,798	$	1,999	$	—
Total cash equivalents		70,797		68,798		1,999		—

United States Treasury securities		8,213		8,213		—		—
Corporate debt securities		11,973		—		11,973		—
Commercial paper		13,090		—		13,090		—
Investments		33,276		8,213		25,063		—

Total	$	104,073	$	77,011	$	27,062	$	—


	As of March 31, 2021
	TOTAL		Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets:
Cash equivalents	$	75,115	$	75,115	$	—	$	—
Total cash equivalents		75,115		75,115		—		—

United States Treasury securities		3,706		3,706		—		—
Corporate debt securities		6,892		—		6,892		—
Commercial paper		9,892		—		9,892		—
Investments		20,490		3,706		16,784		—

Total	$	95,605	$	78,821	$	16,784	$	—

XML 34 R25.htm IDEA: XBRL DOCUMENT

Term Loan (Tables)

3 Months Ended

Mar. 31, 2021

Debt Disclosure [Abstract]

Schedule of Total Term Loan and Unamortized Debt Discount

Total term loan and unamortized debt discount balances are as follows (in thousands):

	March 31, 2021
Face value	$	20,000
Less: discount		(647	)
Total	$	19,353
Less: current portion		(4,838	)
Total	$	14,515

Schedule of Future Principal Payments Due

As of March 31, 2021, future principal payments due under the 2019 Loan Agreement are as follows (in thousands):

Year ended:
December 31, 2021	$	2,500
December 31, 2022		10,000
December 31, 2023		7,500
Total	$	20,000

XML 35 R26.htm IDEA: XBRL DOCUMENT

Stock-Based Compensation (Tables)

3 Months Ended

Mar. 31, 2021

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Schedule of Estimated Fair Value of Options Valuation Assumptions

The fair value of options at date of grant was estimated using the Black-Scholes option-pricing model with the following assumptions:

	Three Months Ended March 31,
	2020		2021
Risk-free interest rate	0.93% - 1.71%		0.50% - 0.72%
Expected dividend yield	0%		0%
Expected life	5.5-6.6 years		5.5-6.7 years
Expected volatility	72%-73%		72%-74%
Weighted-average grant date fair value	$	3.91	$	4.36

Summary of Information about Stock Option Activity

The following table summarizes information about stock option activity during the three months ended March 31, 2021 (in thousands, except share and per share data):

	NUMBER OF SHARES			WEIGHTED- AVERAGE EXERCISE PRICE		WEIGHTED- AVERAGE REMAINING CONTRACTUAL TERM		AGGREGATE INTRINSIC VALUE
Outstanding, December 31, 2020		2,224,913		$	6.26
Granted		785,406			6.84
Exercised		(2,500	)		3.81
Forfeited		(202,790	)		7.62
Outstanding, March 31, 2021		2,805,029		$	6.32		8.18	$	2,926
Vested and exercisable, March 31, 2021		1,125,780		$	5.66		6.64	$	2,222
Vested and expected to vest, March 31, 2021		2,013,825		$	6.26		7.76	$	2,541

Schedule of RSU Activity

The following table summarizes information about RSU activity during the three months ended March 31, 2021:

	RSUs			AVERAGE GRANT DATE FAIR VALUE (IN DOLLARS PER SHARE)
Outstanding, December 31, 2020		80,450		$	3.25
Granted		—			—
Vested		(38,200	)		3.25
Forfeited		—			—
RSUs outstanding at March 31, 2021		42,250		$	3.25

Summary of Stock-Based Compensation Expense

	Three Months Ended March 31,
	2020		2021
Research and development	$	144	$	226
General and administrative		364		295
Total	$	508	$	521

XML 36 R27.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies (Tables)

3 Months Ended

Mar. 31, 2021

Commitments And Contingencies Disclosure [Abstract]

Schedule of Maturity Analysis of Annual Undiscounted Cash Flows of Operating Lease Liabilities

The following is a maturity analysis of the annual undiscounted cash flows of the operating lease liabilities as of March 31, 2021 (in thousands):

Year ended:
December 31, 2021	$	401
December 31, 2022		496
Total minimum lease payments		897
Less imputed interest		(69	)
Total	$	828

Schedule of Lease Cost and Other Information of Operating Lease Liabilities

	Three Months Ended March 31,
	2020			2021
Lease cost:
Operating lease cost	$	122		$	122
Short-term lease cost		-			-
Sublease income		(12	)		(13	)
Total lease cost	$	110		$	109
Other information
Cash paid for amounts included in the measurement of lease liabilities	$	173		$	141
Operating cash flows from operating leases	$	(10	)	$	(14	)
Weighted-average remaining lease term - operating leases	2.7 years			1.7 years
Weighted-average discount rate - operating leases		10.1	%		10.1	%

XML 37 R28.htm IDEA: XBRL DOCUMENT

Description of Business and Basis of Presentation - Additional Information (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020	Sep. 30, 2020
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Accumulated deficit	$ (168,766)	$ (161,664)
Cash, cash equivalents, restricted cash, and short-term investments			$ 96,500

XML 38 R29.htm IDEA: XBRL DOCUMENT

Significant Accounting Policies - Additional Information (Details) - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Schedule Of Accounting Policies [Line Items]
Restricted cash	$ 182,000	$ 182,000
Potential interest and penalties associated with uncertain tax positions, accruals	0
Letter of Credit
Schedule Of Accounting Policies [Line Items]
Restricted cash	$ 182,000

XML 39 R30.htm IDEA: XBRL DOCUMENT

Significant Accounting Policies - Schedule of Cash, Cash Equivalents and Restricted Cash (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020	Mar. 31, 2020	Dec. 31, 2019
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents [Abstract]
Cash and cash equivalents	$ 75,837	$ 71,819
Restricted cash	182	182
Cash, cash equivalents and restricted cash	$ 76,019	$ 72,001	$ 75,521	$ 72,806

XML 40 R31.htm IDEA: XBRL DOCUMENT

Net Loss per Share - Computation of Basic and Diluted Net Loss Per Share of Common Stock (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Earnings Per Share [Abstract]
Net loss	$ (7,102)	$ (7,092)
Weighted-average shares used in computing net loss per share	27,336,724	20,218,473
Net loss per share, basic and diluted	$ (0.26)	$ (0.35)

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794

+ Details

XML 41 R32.htm IDEA: XBRL DOCUMENT

Net Loss per Share - Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share (Details) - shares	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Anti-dilutive securities excluded from calculation of diluted net loss per share	2,847,279	2,181,055
Stock Options to Purchase Common Stock
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Anti-dilutive securities excluded from calculation of diluted net loss per share	2,805,029	2,058,355
Unvested Restricted Stock Units
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Anti-dilutive securities excluded from calculation of diluted net loss per share	42,250	122,700

XML 42 R33.htm IDEA: XBRL DOCUMENT

Investments - Summary of Available-for-Sale Classified Investments (Details) $ in Thousands	Mar. 31, 2021 USD ($)
Marketable Securities [Line Items]
Cost Basis	$ 20,491
Accumulated Unrealized Gains	1
Accumulated Unrealized Losses	(2)
Fair Value	20,490
United States Treasury Securities
Marketable Securities [Line Items]
Cost Basis	3,705
Accumulated Unrealized Gains	1
Fair Value	3,706
Corporate Debt Securities
Marketable Securities [Line Items]
Cost Basis	6,894
Accumulated Unrealized Losses	(2)
Fair Value	6,892
Commercial Paper
Marketable Securities [Line Items]
Cost Basis	9,892
Fair Value	$ 9,892

XML 43 R34.htm IDEA: XBRL DOCUMENT

Investments - Summary of Amortized Cost and Fair Value of Available-for-Sale Investments by Contract Maturity (Details) $ in Thousands	Mar. 31, 2021 USD ($)
Investments Debt And Equity Securities [Abstract]
Amortized Cost, Due in one year or less	$ 20,491
Amortized Cost, Total	20,491
Fair Value, Due in one year or less	20,490
Fair Value, Total	$ 20,490

XML 44 R35.htm IDEA: XBRL DOCUMENT

Property and Equipment - Schedule of Purchased Property and Equipment (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Property Plant And Equipment [Line Items]
Property and equipment, gross	$ 229	$ 229
Less: Accumulated depreciation	(144)	(136)
Property and equipment, net	$ 85	93
Office Equipment
Property Plant And Equipment [Line Items]
ESTIMATED USEFUL LIFE	5 years
Property and equipment, gross	$ 10	10
Office Furniture
Property Plant And Equipment [Line Items]
ESTIMATED USEFUL LIFE	7 years
Property and equipment, gross	$ 116	116
Computer Equipment
Property Plant And Equipment [Line Items]
ESTIMATED USEFUL LIFE	3 years
Property and equipment, gross	$ 8	8
Leasehold Improvements
Property Plant And Equipment [Line Items]
ESTIMATED USEFUL LIFE	Life of lease
Property and equipment, gross	$ 95	$ 95

XML 45 R36.htm IDEA: XBRL DOCUMENT

Property and Equipment - Additional Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Property Plant And Equipment [Abstract]
Depreciation expense	$ 8,000	$ 8,000

XML 46 R37.htm IDEA: XBRL DOCUMENT

Accrued Expenses - Schedule of Accrued Expenses (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Accrued Liabilities Current [Abstract]
Contract research and development	$ 2,467	$ 2,274
Employee compensation and related costs	689	1,978
Consulting and professional service fees	203	364
Interest	88	88
Financing related costs	86	43
State taxes	52	40
Total accrued expenses	$ 3,585	$ 4,787

XML 47 R38.htm IDEA: XBRL DOCUMENT

Fair Value of Financial Instruments - Summary of Assets Measured at Fair Value on Recurring Basis (Details) - Fair Value, Measurements, Recurring - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Assets:
Cash equivalents	$ 75,115	$ 70,797
Investments	20,490	33,276
Total	95,605	104,073
United States Treasury Securities
Assets:
Investments		8,213
Corporate Debt Securities
Assets:
Investments	6,892	11,973
Commercial Paper
Assets:
Investments	9,892	13,090
United States Treasury Securities
Assets:
Investments	3,706
Quoted Prices in Active Markets (Level 1) [Member]
Assets:
Cash equivalents	75,115	68,798
Investments	3,706	8,213
Total	78,821	77,011
Quoted Prices in Active Markets (Level 1) [Member] \| United States Treasury Securities
Assets:
Investments		8,213
Quoted Prices in Active Markets (Level 1) [Member] \| United States Treasury Securities
Assets:
Investments	3,706
Significant Other Observable Inputs (Level 2) [Member]
Assets:
Cash equivalents		1,999
Investments	16,784	25,063
Total	16,784	27,062
Significant Other Observable Inputs (Level 2) [Member] \| Corporate Debt Securities
Assets:
Investments	6,892	11,973
Significant Other Observable Inputs (Level 2) [Member] \| Commercial Paper
Assets:
Investments	$ 9,892	$ 13,090

XML 48 R39.htm IDEA: XBRL DOCUMENT

Term Loan - Additional Information (Details) - USD ($)	1 Months Ended		3 Months Ended
Term Loan - Additional Information (Details) - USD ($)	Sep. 30, 2019	May 31, 2017	Mar. 31, 2021	Mar. 31, 2020
Debt Instrument [Line Items]
Fair value adjustment to derivative liability				$ 30,000
SLR Investment Corp. and Silicon Valley Bank \| 2017 Loan Agreement
Debt Instrument [Line Items]
Loan and security agreement, amount		$ 10,000,000
Loan agreement, maturity date		May 01, 2021
Payment of final fee	$ 325,000
Unpaid borrowings		$ 10,000,000
SLR Investment Corp. and Silicon Valley Bank \| 2019 Loan Agreement
Debt Instrument [Line Items]
Loan and security agreement, amount	$ 20,000,000		$ 20,000,000
Loan agreement, maturity date	Sep. 17, 2023
Loan agreement, term	4 years
Debt instrument, interest rate terms			The interest rate under the 2019 Loan Agreement is the higher of (i) LIBOR plus 7.95% or (ii) 10.18%
Debt instrument, effective interest rate			10.18%
Exit fee, percentage			4.00%
Exit fee			$ 800,000
Derivative liability recorded against exit fee obligation			763,000
Fair value adjustment to derivative liability			30,000
Unpaid borrowings	$ 20,000,000		20,000,000
Amortization of debt discount			$ 87,000	81,000
Prepayment premium percentage after year two			0.50%
Final payment fee			$ 500,000
Amortization of final payment fee			$ 40,000	$ 40,000
Increase in interest rate on default			5.00%
SLR Investment Corp. and Silicon Valley Bank \| 2019 Loan Agreement \| Minimum
Debt Instrument [Line Items]
Interest rate, minimum			10.18%
Prepayment premium percentage			1.00%
SLR Investment Corp. and Silicon Valley Bank \| 2019 Loan Agreement \| Maximum
Debt Instrument [Line Items]
Prepayment premium percentage			3.00%
SLR Investment Corp. and Silicon Valley Bank \| 2019 Loan Agreement \| Libor
Debt Instrument [Line Items]
Basis spread on variable base rate			7.95%

XML 49 R40.htm IDEA: XBRL DOCUMENT

Term Loan - Schedule of Total Term Loan and Unamortized Debt Discount (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Debt Instrument [Line Items]
Less: current portion	$ (4,838)	$ (2,408)
Total	14,515	$ 16,858
2019 Loan Agreement \| SLR Investment Corp. and Silicon Valley Bank
Debt Instrument [Line Items]
Loan and security agreement, amount	20,000
Less: discount	(647)
Total	19,353
Less: current portion	(4,838)
Total	$ 14,515

XML 50 R41.htm IDEA: XBRL DOCUMENT

Term Loan - Schedule of Future Principal Payments Due (Details) - 2019 Loan Agreement - SLR Investment Corp. and Silicon Valley Bank $ in Thousands	Mar. 31, 2021 USD ($)
Debt Instrument [Line Items]
December 31, 2021	$ 2,500
December 31, 2022	10,000
December 31, 2023	7,500
Total	$ 20,000

XML 51 R42.htm IDEA: XBRL DOCUMENT

Stockholders' Equity - Additional Information (Details) - USD ($)			3 Months Ended
	Mar. 23, 2021	Aug. 23, 2019	Mar. 31, 2021	Mar. 31, 2020
2019 ATM Agreement \| Legal Accounting and Other Costs
Stockholders Equity Note [Line Items]
Stock issuance cost		$ 189,000
2019 ATM Agreement \| Additional Paid-in Capital \| Legal Accounting and Other Costs
Stockholders Equity Note [Line Items]
Stock issuance cost				$ 135,000
2019 ATM Agreement \| Jefferies \| Common Stock
Stockholders Equity Note [Line Items]
Percentage of commission on gross sales proceeds		3.00%
Number of shares sold				1,502,892
Proceeds from sale of shares,Net				$ 10,400,000
2019 ATM Agreement \| Jefferies \| Common Stock \| Maximum
Stockholders Equity Note [Line Items]
Aggregate offering price		$ 15,000,000
2019 ATM Agreement \| Jefferies \| Common Stock \| Weighted Average
Stockholders Equity Note [Line Items]
Selling price per share				$ 7.13
2021 ATM Agreement \| Cowen \| Common Stock
Stockholders Equity Note [Line Items]
Proceeds from sale of shares,Net			$ 0
2021 ATM Agreement \| Cowen \| Common Stock \| Maximum
Stockholders Equity Note [Line Items]
Aggregate offering price	$ 50,000,000
Percentage of commission on gross sales proceeds	3.00%

XML 52 R43.htm IDEA: XBRL DOCUMENT

Stock-Based Compensation - Additional Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Additional options granted	785,406
Stock option, number of shares outstanding	2,805,029	2,224,913
Unrecognized compensation expense	$ 3,600,000
Recognition period (in years)	2 years 8 months 12 days
Restricted Stock Units (RSUs)
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Unrecognized compensation expense	$ 41,000
Recognition period (in years)	1 year
Performance Shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Additional options granted	112,050
2017 Stock Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock option and incentive plan effective date	Nov. 30, 2017
Stock option and incentive plan expiration date	Oct. 31, 2027
Stock option, number of shares outstanding	2,204,341
Number of common shares authorized for issuance	5,051,921
Stock options, available for issuance	2,775,526
Term of option granted	10 years
2017 Stock Plan \| Minimum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock option vesting term	1 year
2017 Stock Plan \| Maximum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock option vesting term	4 years
2017 Stock Plan \| Restricted Stock Units (RSUs)
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of restricted stock units outstanding	42,250
2014 Stock Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock option and incentive plan expiration date	Nov. 30, 2017
Additional options granted	0
Stock option, number of shares outstanding	600,688
Number of options forfeited	359,651

XML 53 R44.htm IDEA: XBRL DOCUMENT

Stock-Based Compensation - Schedule of Estimated Fair Value of Options Valuation Assumptions (Details) - $ / shares	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Risk-free interest rate, minimum	0.50%	0.93%
Risk-free interest rate, maximum	0.72%	1.71%
Expected dividend yield	0.00%	0.00%
Expected volatility, minimum	72.00%	72.00%
Expected volatility, maximum	74.00%	73.00%
Weighted-average grant date fair value	$ 4.36	$ 3.91
Minimum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected life	5 years 6 months	5 years 6 months
Maximum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected life	6 years 8 months 12 days	6 years 7 months 6 days

XML 54 R45.htm IDEA: XBRL DOCUMENT

Stock-Based Compensation - Summary of Information about Stock Option Activity (Details) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2021 USD ($) $ / shares shares
NUMBER OF SHARES
Number of shares outstanding, beginning balance \| shares	2,224,913
Additional options granted \| shares	785,406
Number of shares exercised \| shares	(2,500)
Number of shares forfeited \| shares	(202,790)
Number of shares outstanding, ending balance \| shares	2,805,029
Vested and exercisable, ending balance \| shares	1,125,780
Vested and expected to vest, ending balance \| shares	2,013,825
WEIGHTED-AVERAGE EXERCISE PRICE
Weighted average exercise prices, outstanding beginning balance \| $ / shares	$ 6.26
Weighted average exercise prices, granted \| $ / shares	6.84
Weighted average exercise prices, exercised \| $ / shares	3.81
Weighted average exercise prices, forfeited \| $ / shares	7.62
Weighted average exercise prices, outstanding ending balance \| $ / shares	6.32
Weighted average exercise prices, vested and exercisable ending balance \| $ / shares	5.66
Weighted average exercise prices, vested and expected to vest ending balance \| $ / shares	$ 6.26
WEIGHTED-AVERAGE REMAINING CONTRACTUAL TERM
Weighted average remaining contractual term, outstanding	8 years 2 months 4 days
Weighted average remaining contractual term, vested and exercisable	6 years 7 months 20 days
Weighted average remaining contractual term, vested and expected to vest	7 years 9 months 3 days
AGGREGATE INTRINSIC VALUE
Aggregate intrinsic value, outstanding ending balance \| $	$ 2,926
Aggregate intrinsic value, vested and exercisable ending balance \| $	2,222
Aggregate intrinsic value, vested and expected to vest ending balance \| $	$ 2,541

XML 55 R46.htm IDEA: XBRL DOCUMENT

Stock-Based Compensation - Schedule of RSU Activity (Details) - Restricted Stock Units (RSUs)	3 Months Ended
	Mar. 31, 2021 $ / shares shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
RSUs Outstanding, December 31, 2020 \| shares	80,450
RSUs Vested \| shares	(38,200)
RSUs outstanding at March 31, 2021 \| shares	42,250
AVERAGE GRANT DATE FAIR VALUE, Outstanding, December 31, 2020 \| $ / shares	$ 3.25
AVERAGE GRANT DATE FAIR VALUE, Vested \| $ / shares	3.25
AVERAGE GRANT DATE FAIR VALUE, RSUs outstanding at March 31, 2021 \| $ / shares	$ 3.25

XML 56 R47.htm IDEA: XBRL DOCUMENT

Stock-Based Compensation - Summary of Stock Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Total stock-based compensation expense	$ 521	$ 508
Research and Development
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Total stock-based compensation expense	226	144
General and Administrative
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Total stock-based compensation expense	$ 295	$ 364

XML 57 R48.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies - Additional Information (Details) - USD ($)	1 Months Ended	3 Months Ended
	Feb. 28, 2018	Mar. 31, 2021	Dec. 31, 2020
Commitments And Contingencies [Line Items]
Operating leases expire		2022
Restricted cash		$ 182,000	$ 182,000
Short-term lease asset		717,000	815,000
Short-term lease liability		472,000	$ 460,000
Operating sublease term	3 years
Short-term Leases Recognized on Straight-line Basis
Commitments And Contingencies [Line Items]
Short-term lease asset		0
Short-term lease liability		0
Letter of Credit
Commitments And Contingencies [Line Items]
Restricted cash		182,000
Letter of Credit \| Lease Agreement Require Standby Letter of Credit
Commitments And Contingencies [Line Items]
Restricted cash		$ 182,000

XML 58 R49.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies - Schedule of Maturity Analysis of Annual Undiscounted Cash Flows of Operating Lease Liabilities (Details) $ in Thousands	Mar. 31, 2021 USD ($)
Year ended:
December 31, 2021	$ 401
December 31, 2022	496
Total minimum lease payments	897
Less imputed interest	(69)
Total	$ 828

XML 59 R50.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies - Schedule of Lease Cost and Other Information of Operating Lease Liabilities (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Lease cost:
Operating lease cost	$ 122	$ 122
Sublease income	(13)	(12)
Total lease cost	109	110
Other information
Cash paid for amounts included in the measurement of lease liabilities	141	173
Operating cash flows from operating leases	$ (14)	$ (10)
Weighted-average remaining lease term - operating leases	1 year 8 months 12 days	2 years 8 months 12 days
Weighted-average discount rate - operating leases	10.10%	10.10%

EXCEL 60 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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end XML 61 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 62 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 63 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.1 html 114 311 1 false 43 0 false 4 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) Statements 2 false false R3.htm 100020 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) Statements 3 false false R4.htm 100030 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) Statements 4 false false R5.htm 100040 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) Statements 5 false false R6.htm 100050 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Statements 6 false false R7.htm 100060 - Disclosure - Description of Business and Basis of Presentation Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentation Description of Business and Basis of Presentation Notes 7 false false R8.htm 100070 - Disclosure - Significant Accounting Policies Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureSignificantAccountingPolicies Significant Accounting Policies Notes 8 false false R9.htm 100080 - Disclosure - Net Loss per Share Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureNetLossPerShare Net Loss per Share Notes 9 false false R10.htm 100090 - Disclosure - Investments Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureInvestments Investments Notes 10 false false R11.htm 100100 - Disclosure - Property and Equipment Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosurePropertyAndEquipment Property and Equipment Notes 11 false false R12.htm 100110 - Disclosure - Accrued Expenses Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureAccruedExpenses Accrued Expenses Notes 12 false false R13.htm 100120 - Disclosure - Fair Value of Financial Instruments Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureFairValueOfFinancialInstruments Fair Value of Financial Instruments Notes 13 false false R14.htm 100130 - Disclosure - Term Loan Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureTermLoan Term Loan Notes 14 false false R15.htm 100140 - Disclosure - Stockholders' Equity Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureStockholdersEquity Stockholders' Equity Notes 15 false false R16.htm 100150 - Disclosure - Stock-Based Compensation Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureStockBasedCompensation Stock-Based Compensation Notes 16 false false R17.htm 100160 - Disclosure - Commitments and Contingencies Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 17 false false R18.htm 100170 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureSignificantAccountingPoliciesPolicies Significant Accounting Policies (Policies) Policies http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureSignificantAccountingPolicies 18 false false R19.htm 100180 - Disclosure - Significant Accounting Policies (Tables) Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureSignificantAccountingPoliciesTables Significant Accounting Policies (Tables) Tables http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureSignificantAccountingPolicies 19 false false R20.htm 100190 - Disclosure - Net Loss per Share (Tables) Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureNetLossPerShareTables Net Loss per Share (Tables) Tables http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureNetLossPerShare 20 false false R21.htm 100200 - Disclosure - Investments (Tables) Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureInvestmentsTables Investments (Tables) Tables http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureInvestments 21 false false R22.htm 100210 - Disclosure - Property and Equipment (Tables) Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosurePropertyAndEquipmentTables Property and Equipment (Tables) Tables http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosurePropertyAndEquipment 22 false false R23.htm 100220 - Disclosure - Accrued Expenses (Tables) Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureAccruedExpensesTables Accrued Expenses (Tables) Tables http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureAccruedExpenses 23 false false R24.htm 100230 - Disclosure - Fair Value of Financial Instruments (Tables) Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsTables Fair Value of Financial Instruments (Tables) Tables http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureFairValueOfFinancialInstruments 24 false false R25.htm 100240 - Disclosure - Term Loan (Tables) Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureTermLoanTables Term Loan (Tables) Tables http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureTermLoan 25 false false R26.htm 100250 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureStockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureStockBasedCompensation 26 false false R27.htm 100260 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureCommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureCommitmentsAndContingencies 27 false false R28.htm 100270 - Disclosure - Description of Business and Basis of Presentation - Additional Information (Details) Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetails Description of Business and Basis of Presentation - Additional Information (Details) Details 28 false false R29.htm 100280 - Disclosure - Significant Accounting Policies - Additional Information (Details) Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails Significant Accounting Policies - Additional Information (Details) Details 29 false false R30.htm 100290 - Disclosure - Significant Accounting Policies - Schedule of Cash, Cash Equivalents and Restricted Cash (Details) Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfCashCashEquivalentsAndRestrictedCashDetails Significant Accounting Policies - Schedule of Cash, Cash Equivalents and Restricted Cash (Details) Details 30 false false R31.htm 100300 - Disclosure - Net Loss per Share - Computation of Basic and Diluted Net Loss Per Share of Common Stock (Details) Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureNetLossPerShareComputationOfBasicAndDilutedNetLossPerShareOfCommonStockDetails Net Loss per Share - Computation of Basic and Diluted Net Loss Per Share of Common Stock (Details) Details 31 false false R32.htm 100310 - Disclosure - Net Loss per Share - Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share (Details) Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfNetLossPerShareDetails Net Loss per Share - Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share (Details) Details 32 false false R33.htm 100320 - Disclosure - Investments - Summary of Available-for-Sale Classified Investments (Details) Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureInvestmentsSummaryOfAvailableForSaleClassifiedInvestmentsDetails Investments - Summary of Available-for-Sale Classified Investments (Details) Details 33 false false R34.htm 100330 - Disclosure - Investments - Summary of Amortized Cost and Fair Value of Available-for-Sale Investments by Contract Maturity (Details) Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureInvestmentsSummaryOfAmortizedCostAndFairValueOfAvailableForSaleInvestmentsByContractMaturityDetails Investments - Summary of Amortized Cost and Fair Value of Available-for-Sale Investments by Contract Maturity (Details) Details 34 false false R35.htm 100340 - Disclosure - Property and Equipment - Schedule of Purchased Property and Equipment (Details) Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosurePropertyAndEquipmentScheduleOfPurchasedPropertyAndEquipmentDetails Property and Equipment - Schedule of Purchased Property and Equipment (Details) Details 35 false false R36.htm 100350 - Disclosure - Property and Equipment - Additional Information (Details) Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetails Property and Equipment - Additional Information (Details) Details 36 false false R37.htm 100360 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Details) Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails Accrued Expenses - Schedule of Accrued Expenses (Details) Details 37 false false R38.htm 100370 - Disclosure - Fair Value of Financial Instruments - Summary of Assets Measured at Fair Value on Recurring Basis (Details) Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsSummaryOfAssetsMeasuredAtFairValueOnRecurringBasisDetails Fair Value of Financial Instruments - Summary of Assets Measured at Fair Value on Recurring Basis (Details) Details 38 false false R39.htm 100380 - Disclosure - Term Loan - Additional Information (Details) Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureTermLoanAdditionalInformationDetails Term Loan - Additional Information (Details) Details 39 false false R40.htm 100390 - Disclosure - Term Loan - Schedule of Total Term Loan and Unamortized Debt Discount (Details) Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureTermLoanScheduleOfTotalTermLoanAndUnamortizedDebtDiscountDetails Term Loan - Schedule of Total Term Loan and Unamortized Debt Discount (Details) Details 40 false false R41.htm 100410 - Disclosure - Term Loan - Schedule of Future Principal Payments Due (Details) Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureTermLoanScheduleOfFuturePrincipalPaymentsDueDetails Term Loan - Schedule of Future Principal Payments Due (Details) Details 41 false false R42.htm 100420 - Disclosure - Stockholders' Equity - Additional Information (Details) Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails Stockholders' Equity - Additional Information (Details) Details 42 false false R43.htm 100430 - Disclosure - Stock-Based Compensation - Additional Information (Details) Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails Stock-Based Compensation - Additional Information (Details) Details 43 false false R44.htm 100440 - Disclosure - Stock-Based Compensation - Schedule of Estimated Fair Value of Options Valuation Assumptions (Details) Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureStockBasedCompensationScheduleOfEstimatedFairValueOfOptionsValuationAssumptionsDetails Stock-Based Compensation - Schedule of Estimated Fair Value of Options Valuation Assumptions (Details) Details 44 false false R45.htm 100450 - Disclosure - Stock-Based Compensation - Summary of Information about Stock Option Activity (Details) Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureStockBasedCompensationSummaryOfInformationAboutStockOptionActivityDetails Stock-Based Compensation - Summary of Information about Stock Option Activity (Details) Details 45 false false R46.htm 100460 - Disclosure - Stock-Based Compensation - Schedule of RSU Activity (Details) Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRSUActivityDetails Stock-Based Compensation - Schedule of RSU Activity (Details) Details 46 false false R47.htm 100470 - Disclosure - Stock-Based Compensation - Summary of Stock Based Compensation Expense (Details) Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails Stock-Based Compensation - Summary of Stock Based Compensation Expense (Details) Details 47 false false R48.htm 100480 - Disclosure - Commitments and Contingencies - Additional Information (Details) Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails Commitments and Contingencies - Additional Information (Details) Details 48 false false R49.htm 100490 - Disclosure - Commitments and Contingencies - Schedule of Maturity Analysis of Annual Undiscounted Cash Flows of Operating Lease Liabilities (Details) Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfMaturityAnalysisOfAnnualUndiscountedCashFlowsOfOperatingLeaseLiabilitiesDetails Commitments and Contingencies - Schedule of Maturity Analysis of Annual Undiscounted Cash Flows of Operating Lease Liabilities (Details) Details 49 false false R50.htm 100510 - Disclosure - Commitments and Contingencies - Schedule of Lease Cost and Other Information of Operating Lease Liabilities (Details) Sheet http://www.scpharmaceuticals.com/20210331/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseCostAndOtherInformationOfOperatingLeaseLiabilitiesDetails Commitments and Contingencies - Schedule of Lease Cost and Other Information of Operating Lease Liabilities (Details) Details 50 false false All Reports Book All Reports scph-20210331.xml scph-20210331.xsd scph-20210331_cal.xml scph-20210331_def.xml scph-20210331_lab.xml scph-20210331_pre.xml http://fasb.org/srt/2020-01-31 http://fasb.org/us-gaap/2020-01-31 http://xbrl.sec.gov/dei/2020-01-31 true true ZIP 65 0001564590-21-026969-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001564590-21-026969-xbrl.zip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�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end